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Abstract 
Isometric handgrip (IHG) training lowers resting arterial blood pressure (BP) in older, 
normotensive adults and it has been proposed that repeated exposure to oxidative stress, 
via IHG-induced ischemia-reperfusion (IR), could be an underlying mechanism.  The 
objectives were to quantify the IHG neurovascular stimulus, determine if this IHG 
protocol elicits systemic vascular effects, and compare the response of the IHG stimulus 
to an IR cuff protocol.  Vascular reactivity, assessed via flow-mediated dilation (FMD) 
and strain-gauge plethysmography (RVF), was determined prior-to and immediately-post 
an IHG bout in the exercised arm, non-exercised arm, and after IR in the reperfused arm.  
No significant differences were found in FMD or RVF after each of the three bouts.  
These findings suggest that vascular reactivity remains unchanged in either limb, both in 
response to an acute IHG bout and a complementary IR cuff protocol, indicating 
oxidative stress may not be a part of the acute IHG stimulus. 
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1.1 Hypertension 
1.1.1 Introduction  
 Cardiovascular disease (CVD) is recognized as the leading cause of death 
worldwide (WHO, 2013).  CVD is characterized by disorders of the heart and blood 
vessels and includes coronary heart disease, cerebrovascular disease, elevated blood 
pressure, peripheral arterial disease, rheumatic heart disease, congenital heart disease and 
heart failure (WHO, 2013).  Empirically, it is estimated that CVD was responsible for 
17.3 million deaths worldwide in 2008 (WHO, 2013).  Further, it is projected that this 
rate will grow to almost 23.6 million deaths per year by 2030 (WHO, 2013).  In Canada, 
CVD is a leading cause of mortality in both males and females (Statistics Canada, 2009).  
Economically, total costs relating to CVD in Canada were estimated to be $20.9 billion in 
2005, with projections to $28.3 billion by 2020 (Theriault et al., 2010).  Given the 
widespread prevalence and projected increases, coupled with the economic burden of this 
disease, the prevention and control of CVD is very important. 
 Although CVD is the leading cause of mortality worldwide (WHO, 2013) it is 
considered a preventable disease through the modulation of a number of behavioural risk 
factors.  These behavioural risk factors include diet quality, physical activity status, 
stress, tobacco use, alcohol consumption, body composition, blood pressure, and blood 
cholesterol (PHAC, 2009).  It has been estimated that these behavioural risk factors are 
responsible for approximately 80% of CVD (WHO, 2013).  Additionally, there are non-
modifiable risk factors, including age, gender, family history, ethnicity, and medical 
history that also contribute to the development of CVD (PHAC, 2009).  While the 
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relative contributions of each of these factors is difficult to quantify, it appears that 
hypertension (HT), or chronically sustained elevations of systolic and/or diastolic arterial 
blood pressure (BP), accounts for approximately 7.5 million deaths worldwide each year 
and is a leading modifiable risk factor for CVD (WHO, 2013). 
1.1.2 Arterial Blood Pressure Regulation 
Prior to discussing the pathophysiology of HT, it is important to understand basic 
arterial BP control in a healthy physiological state. Efficient function of the 
cardiovascular system requires the maintenance of adequate arterial blood pressure (BP) 
during the cardiac excitation-relaxation cycle to allow for adequate perfusion of bodily 
tissues (Herd, 1970).  Arterial BP can be sub-divided into systolic (SBP) and diastolic 
(DBP) components, which represent the different phases of cardiac contraction.  SBP 
occurs during the period of cardiac contraction and represents the pressure that the blood 
exerts on the artery walls during ventricular systole (Herd, 1970).  In contrast, DBP 
occurs during the period between cardiac contractions and represents the pressure exerted 
by the blood on vessel walls during cardiac relaxation and gives an indication of 
peripheral resistance (Herd, 1970).  In individuals with normal resting arterial BP, 
measurements of pressure during systole average <120 mmHg, while measurements 
during diastole average 80 mmHg (Chobanian et al., 2003).   
 Arterial BP is derived from the product of cardiac output (Q) and total peripheral 
resistance (TPR).  Q is the product of the rate of contraction of the heart (heart rate; HR) 
and the volume of blood pumped per contraction (stroke volume; SV).  TPR is the sum of 
the resistance to blood flow provided by the peripheral vasculature within the entire 
systemic circulation (Washburn, 1921).  TPR is greatly influenced by changes in the 
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radius of the peripheral vasculature through vasoconstriction or vasodilation.  As such, 
modulation of BP may occur through changes in Q, via HR and/or SV, and/or through 
changes of the TPR within the system.  These pressures are tightly controlled by a 
number of innate pathways including neural, hormonal, vascular, and genetic BP control 
mechanisms. 
Innate Blood Pressure Control Mechanisms 
 Regulation of arterial BP is controlled through the coordinated efforts of neural, 
hormonal, vascular, and genetic control mechanisms.  These mechanisms function via 
modulation of Q via HR and/or SV, as well as TPR, through alterations in vasodilation 
and vasoconstriction of the vascular smooth muscle.   
 Neural Blood Pressure Control 
Neurological control of BP functions predominantly through the integration of the 
sympathetic (SNS) and parasympathetic nervous systems (PNS) within the autonomic 
nervous system (ANS).  In brief, sympathetic activation augments resistance to blood 
flow, which raises arterial BP via increased TPR (Dampney et al., 2002), and also acts to 
increase HR and force of myocardial contraction, which lead to increases in both Q and 
BP (Dampney et al., 2002).  In opposing fashion to the SNS, PNS stimulation leads to a 
significant decrease in HR and a small decrease in cardiac contractility (Dampney et al., 
2002).  The net neural effect on the cardiovascular system is dependent on the balance of 
stimulation between these two systems.   
Coordination of the SNS and PNS is controlled by a brain region known as central 
command (CC), which sends information to the cardiovascular control center (CCC) 
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(Dampney et al., 2002; Eldridge et al., 1985).  The CCC can be classified as an 
integration center as it receives both ascending and descending information when 
coordinating a response.  CC is able to modulate the balance of the ANS through 
innervation of the CCC in response to the added stress of exercise (Victor et al., 1995).  
Additional sensory information is provided through signals received from arterial 
baroreceptors, chemoreceptors, and muscle afferent receptors. 
 Arterial baroreceptors contribute to the regulation of arterial BP through afferent 
feedback to the CCC (Lafranchi & Somers, 2002).  These receptors, located in the heart, 
pulmonary vessels, and throughout the arterial walls of the carotid artery, indirectly 
monitor changes in arterial BP.  As baroreceptors do not sense pressure, but the 
conformational change in the vessel wall caused by pressure changes, they are classified 
as stretch receptors (Angell-James, 1971).  Afferent feedback allows the CCC to 
modulate the relative contributions of the SNS and PNS to maintain arterial BP around a 
homeostatic set point (Lafranchi & Somers, 2002).  An increase in arterial BP triggers an 
increase in the frequency of impulses sent from the baroreceptors to the CCC resulting in 
increased PNS and decreased SNS activation (Lafranchi & Somers, 2002).  Likewise, a 
decrease in arterial BP triggers a decrease in the frequency of impulse generation from 
the baroreceptors to the CCC resulting in increased SNS activation (Lafranchi & Somers, 
2002). 
 The composition of metabolites within the circulating blood serves as a further 
stimulus to arterial BP regulation mechanisms.  Chemoreceptors, located within the 
carotid and aortic bodies, sense changes in the partial pressure of oxygen (PaO2) and 
carbon dioxide (PaCO2), as well as hydrogen ion (H+) concentrations, within the arterial 
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blood (Prabhakar, 2000).  These receptors send afferent feedback to the CCC to induce 
SNS activation in response to reductions in PaO2, increases in H+ concentration, and 
increases in PaCO2 (Prabhakar, 2000; Dampney et al., 2002).  The resulting response 
consists of vasoconstriction of the vascular beds, increasing TPR, coupled with increases 
in ventilation in an effort to increase arterial BP. 
 Muscular afferent receptors function to regulate arterial BP in similar manner to 
the receptors described above.  Type III afferent receptors, or mechanoreceptors, sense 
stretch and deformation due to pressure, whereas type IV afferents, or metaboreceptors, 
sense changes in the muscular milieu (Leshnower et al., 2001).  More specifically, type 
IV receptors are stimulated by chemicals and metabolic by-products of muscle 
contraction such as lactic acid, dipronated phosphate, potassium (K+), bradykinin, 
serotonin, and adenosine (Leshnower et al., 2001).  Information provided by these 
receptors is processed in the CCC and the response is an alteration of the balance of the 
SNS and PNS within the ANS, leading to changes in HR and arterial BP (Leshnower et 
al., 2001; Pawelczyk et al., 1997). 
 Hormonal Blood Pressure Control 
 Certain hormones of the human body have a profound impact on the regulation of 
an individual’s arterial BP.  The most influential BP modulating hormones include the 
catecholamines epinephrine (E) and norepinephrine (NE), acetylcholine (ACh), the renin-
angiotensin-aldosterone system (RAAS), arginine vasopressin (AVP), and atrial 
natriuretic peptide (ANP).  The coordinated efforts of these hormones, along with 
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vascular, neural, and genetic mechanisms, function to defend homeostatic arterial BP 
levels. 
 The sympathetic nervous system is the distributor of the catecholamines E and 
NE, which elicit various cardiovascular responses based on which receptor they bind to 
and its location within the body.  SNS nerve fibers form a synaptic junction with vascular 
beds within a close proximity to effectively distribute these catecholamines.  When the 
SNS is stimulated it triggers the release of E and NE from the adrenal glands (Mannelli et 
al., 1990).  E is released directly into the systemic circulation, whereas NE is released 
predominantly at the synaptic junction between the SNS nerve fiber and the vascular 
beds, though a small amount does also reach systemic circulation (Mannelli et al., 1990).  
E and NE regulate arterial BP through modulating both Q and TPR depending on specific 
receptor binding (Mannelli et al., 1990).   
 There are two main types of receptors bound by E and NE, the α-adrenergic 
receptors and the β-adrenergic receptors (Ruffolo et al., 1991).  These are further sub-
divided based on location and mechanism of action.  α-adrenergic receptors are divided 
into α1-receptors, located within most sympathetic target organs, except the heart, and 
α2-receptors, located within the membranes of the NE nerve endings within the synaptic 
junction (Mannelli et al., 1990).  β-adrenergic receptors are divided into β1-receptors, 
located within the heart, kidneys, liver, and adipose tissues, and β2-receptors, located 
within most sympathetic target organs (Mannelli et al., 1990).  E’s binding to the α-
adrenergic receptors elicits a vasoconstrictory response, whereas it elicits a vasodilatory 
response when bound to β-adrenergic receptors (Mannelli et al., 1990).  NE binds to post-
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synaptic α-adrenergic receptors within the synaptic junction to elicit a vasoconstrictory 
response in the target vascular beds (Ruffolo et al., 1991).  Modification of the state of 
smooth muscle contraction in the target vasculature regulates arterial BP through changes 
in TPR. 
 The catecholamines also influence Q through changes in HR.  This pathway is 
mediated through second messenger cellular cascades initiated by cyclic adenosine 
monophosphate (cAMP) (Opie, 2004).  cAMP is produced through the stimulation of β-
adrenergic receptors by E within the cardiac cells, which then initiates cAMP-dependent 
protein kinase A (PKA) (Krammer, 1988).  PKA increases HR by accelerating the rate of 
impulse generation at the sino-atrial (SA) node, as well as increasing diastolic filling 
time, which increases arterial BP (Larsson, 2010). 
 The PNS can regulate arterial BP through distribution of ACh, a neurotransmitter 
released from PNS nerve fibers (Dale et al., 1936).  ACh regulates arterial BP through 
binding to muscarinic receptors within the cardiac cell membrane and inhibiting adenyl 
cyclase, which then inhibits elevated intracellular cAMP concentrations (Brodde & 
Michel, 1999).  A decrease in intracellular cAMP reduces calcium channel 
phosphorylation, reducing the number of open calcium channels and inhibiting calcium 
influx (Brodde & Michel, 1999).  As sarcoplasmic reticulum (SR) calcium release is 
dependent upon the influx of extracellular calcium, a process termed calcium-induced 
calcium release (CICR), and SR calcium release provokes cardiac contraction, a reduced 
influx depresses cardiac contractility, and therefore Q, leading to reduced arterial BP 
(Fabiato, 1983). 
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 ACh can also reduce arterial BP through decreases in HR.  The release of ACh 
can hyperpolarize the SA node, which increases the time required to reach the threshold 
potential for excitation (Brodde & Michel, 1999).  As such, there is a greater amount of 
time between cardiac contractions, lowering HR, therefore lowering arterial BP. 
 The most important long-term arterial BP regulation system involves the 
integration of the kidneys and adrenal glands, as well as a number of hormones and 
enzymes, within the RAAS.  The efficiency of this system stems from the effects it exerts 
on both total blood fluid volume and vascular tone.  The RAAS is initiated when renin, a 
glycoprotein enzyme, is released via exocytosis from the kidneys (Vander, 1967).  Renin 
is then able to facilitate the conversion of angiotensinogen, a pro-hormone secreted by the 
liver, to angiotensin I (Nguyen et al., 2002).  Angiotensin I is considered an inactive form 
of this protein and is further modified by the angiotensin-converting enzyme (ACE) into 
angiotensin II, considered an active form (Donoghue et al., 2000).  Angiotensin II is a 
potent vasoconstrictor and, as such, will have a direct effect on arterial BP through 
increases in TPR.  Angiotensin II also triggers the release of aldosterone from the adrenal 
cortex (Carey & Siragy, 2003).  Aldosterone is a hormone that promotes fluid retention 
through the conservation of sodium, which increases total blood fluid volume and, 
therefore, arterial BP (Leutscher & Johnson, 1954). 
 An increase in arterial BP can induce stretching of the arterial walls within the 
heart.  Cardiac atrial cells release ANP in response to this stretch in an effort to reduce 
arterial BP.  ANP can decrease arterial BP via two different mechanisms.  First, ANP 
prevents vascular vasoconstriction through the inhibition of actin-myosin binding, which 
dilates smooth muscle and reduces TPR (Potter et al., 2009).  Second, by promoting 
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diuresis and sodium excretion, ANP reduces total blood fluid volume, which can also 
decrease arterial BP (deBold et al., 1981). 
 AVP, also referred to as anti-diuretic hormone, is released from the pituitary 
gland in response to a decrease in arterial BP (Henderson & Byron, 2007).  AVP 
increases arterial BP via two mechanisms, which are similar, yet opposite, to that of 
ANP.  AVP can induce vasoconstriction of smooth muscle, increasing TPR and therefore 
BP (Holmes et al., 2004).  Further, AVP also influences fluid balance regulation.  
Through binding to the adenylyl cyclase-coupled vasopressin receptor in the kidney, 
AVP reduces urinary water excretion by promoting water reabsorption through the 
collecting duct (Holmes et al., 2003; Nielsen et al., 1995).  Increased water reabsorption 
elevates blood fluid volume, which increases arterial BP. 
 Local Blood Pressure Control 
 Arterial BP can also be regulated by a number of locally released vasoactive 
substances, which are formed in response to changes in the metabolic needs of the body’s 
organs and tissues (Haddy & Scott, 1968).  Their primary mechanism of action is 
modulating the diameter of smooth muscle, through vasoconstriction and vasodilation, 
modifying TPR and effectively altering arterial BP.  The most common of these 
substances include potassium (K+), adenine derivatives, and endothelium-derived 
substances such as nitric oxide (NȮ) and endothelin-1 (ET-1). 
 K+ release into the interstitial space around arterioles is a byproduct of muscular 
depolarization, and thus increased muscular activity can lead to an accumulation of 
interstitial K+ (Haddy et al., 2006).  An increase in the concentration of K+ stimulates the 
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sodium-potassium (Na+/K+) pump within the membrane of the smooth muscle (Haddy et 
al., 2006).  As the Na+/K+ pump is electrogenic its increased stimulation results in 
hyperpolarization of the smooth muscle cells (Anderson, 1976; Haddy et al., 2006).  
Hyperpolarization of these cells increases the both the stimulus strength and time 
required for depolarization, effectively reducing the rate and magnitude of Ca2+ influx.  
The influx of extracellular Ca2+ is the main mechanism responsible for smooth muscle 
vasoconstriction (Karaki et al., 1997).  As such, decreased Ca2+ influx reduces smooth 
muscle vasoconstriction allowing for increased tissue blood flow, reduced TPR, and 
decreased arterial BP.  Increased tissue blood flow provides added blood supply to meet 
the increased metabolic demands of the working muscle tissue. 
 Derivatives of adenine, including adenosine triphosphate (ATP) and the 
byproducts of its catabolism, adenosine diphosphate (ADP), adenosine monophosphate 
(AMP), and adenosine itself (depending on the location of action) are considered 
vasodilatory substances (Haddy & Scott, 1968).  ATP is a key substrate involved in 
muscular contraction.  As such, a decrease in the concentration of ATP, and an increase 
in the concentration of the byproducts of its catabolism, is an indication of increased 
muscle metabolism.  An increase in these metabolites induces a vasodilatory response in 
the vascular beds supplying the working tissues to meet the increased metabolic demand 
(Haddy & Scott, 1968). 
 The most potent vasoactive substance, NȮ, also evokes a vasodilatory smooth 
muscle response (Steinburg et al., 1994).  The increased metabolic demands of working 
muscle during exercise are met through increased blood flow to these tissues.  Elevations 
in the rate and magnitude of blood flow increase shear stress, the force of the flowing 
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blood against the blood vessel walls, on the vascular endothelium lining the blood vessels 
supplying the muscles.  Shear stress of the vascular walls is a potent stimulator of NȮ 
production (Corson et al., 1996).  Likewise, chemical stimuli (e.g. ACh and bradykinin) 
are also stimulators of endothelial NȮ production (Fleming & Busse, 2003).  NȮ is 
synthesized from the amino acid L-arginine via the NȮ synthase enzyme (eNOS) and 
diffuses out of the vascular endothelium (Moncada & Higgs, 1993).  Once diffused, NȮ 
interacts with the vascular smooth muscle cells activating guanylyl cyclase and causing 
an accumulation of cyclic guanine 3,5 monophosphate (cGMP) (Umans & Levi, 1995).  
Accumulation of cGMP triggers the activation of cGMP-dependent protein kinase, which 
increases myosin light chain (MLC) phosphatase activity (Umans & Levi, 1995; Webb, 
2003).  Increased MLC phosphatase activity inhibits smooth muscle contraction via 
inhibition of the binding of actin and myosin (Umans & Levi, 1995; Webb, 2003).  As 
such, the response is smooth muscle vasodilation, increased blood flow, and decreased 
TPR and arterial BP. 
 Vasodilatory substances such as K+, adenosine derivatives, and NȮ are counter-
balanced by locally released vasoconstrictive substances.  ET-1 is released by the 
endothelium in response to chemical (angiotensin II, catecholamine, cytokine, hypoxic, 
growth factor) or mechanical (shear stress) stimulation (Touyz & Shiffrin, 2003).  ET-1 
induces vasoconstriction when bound to the ETa receptor through the initiation of a 
signaling cascade leading to the release of sequestered Ca2+ and the opening of Ca2+ 
membrane channels (Pollock et al., 1995).  As intracellular Ca2+ determines the 
contractile state of smooth muscle, an increase in intracellular Ca2+ can induce 
vasoconstriction though increased smooth muscle contraction (Karaki et al., 1997).  
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Increased vasoconstriction increases TPR and, therefore, arterial BP.  ET-1 can also 
regulate the contractile state of the smooth muscle via a negative feedback loop.  When 
ET-1 binds to ETb receptors it stimulates the release of NȮ, the potent vasodilator 
described above (Pollock et al., 1995). 
1.1.3 Measurement of Blood Pressure 
 The desire to measure the pressure of blood in the human body has led to the 
evolution of a number of measurement techniques.  On the grandest scale these 
techniques can be divided into invasive or non-invasive measures.  As one might surmise, 
invasive measures of arterial BP involve the insertion of a catheter into the artery to allow 
for direct, continuous recording of arterial BP (Perloff et al., 1993).  Although this is 
considered the gold standard of arterial BP measurement the nature of this technique 
makes it impractical for use in clinical settings (Perloff et al., 1993).  A number of non-
invasive techniques, such as auscultatory sphygmomanometry, automated oscillometry, 
ultrasonography, the finger cuff method of Penaz, and applanation tonometry have been 
developed for non-invasive arterial BP measurement. 
Sphygmomanometry and Auscultation 
 Measurement of arterial BP using sphygmomanometry and auscultation is 
considered the gold standard of non-invasive arterial BP measurement in clinical practice.  
This method involves placement of an inflatable cuff around the arm, above the elbow, to 
be used for brachial artery occlusion.  This cuff is manually inflated to a pressure above 
SBP to fully occlude the artery in preparation for auscultation (Beevers et al., 2001).  
During brachial artery auscultation the pressure of the cuff is manually released at a 
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gradual rate of approximately 2-3 mmHg per second (Beevers et al., 2001).  As the 
pressure of the cuff is released the observer will note a number of Korotkoff sounds.  The 
first Korotkoff sound occurs when the pressure in the cuff drops below systolic arterial 
pressure and blood begins to flow through the artery (Korotkoff, 1905).  The cuff 
pressure at this first Korotkoff sound is representative of SBP (Korotkoff, 1905).  As the 
pressure of the cuff is continually decreased the observer will hear a series of 4 more 
Korotkoff sounds with the last one followed by a state of silence, which signifies DBP 
has been passed (Korotkoff, 1905). 
 Though this method of arterial BP measurement is considered the non-invasive 
gold standard there are notable limitations and disadvantages.  The link between the 
pressure measurement of the cuff and the instance of the various Korotkoff sounds is the 
observer taking the measurement.  As such, measurements may be influenced by terminal 
digit preference, observer prejudice, and/or observer bias (Beevers et al., 2001).  
Additionally, the Korotkoff method has been noted to give SBP and DBP values that are 
lower than direct intra-arterial measures (Holland & Humerfelt, 1964).  These variances 
have been reported to be as great as 25 mmHg in certain cases (Breit & O’Rourke, 1974).  
Lastly, the auscultatory gap, which is a disappearance of the Korotkoff sounds between 
SBP and DBP only to return as deflation continues, may affect measures using this 
method (Pickering et al., 2005).  This phenomenon tends to occur in older individuals 
with wide pulse pressures, but can often be eliminated by elevating the arm overhead for 
30 seconds and returning it to its normal position for measurement (Pickering et al., 
2005).  This technique reduces vascular volume within the arm to allow for a greater 
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inflow of blood and improved Korotkoff sounds during measurement (Pickering et al., 
2005). 
Automatic Oscillometry 
 The automated oscillometric technique, developed by Etienne-Jules Marey in 
1876, measures oscillations in pressure within a sphygmomanometer cuff during gradual 
deflation (Langewouters et al., 1998).  The amplitude of these oscillations first increases 
and then decreases during gradual deflation and the peak amplitude corresponds with 
mean arterial pressure (Mauck et al., 1980; Langewouters et al., 1998).  As these 
oscillations begin well above SBP, and continue below DBP, these values can only be 
indirectly estimated via an empirically derived algorithm (Pickering et al., 2005; 
Langewouters et al., 1998).  This method is advantageous because placement of a 
transducer is not required, allowing for greater variability in cuff placement, and it is less 
susceptible to external noise (Pickering et al., 2005).  The most prominent disadvantage 
of this method is that the oscillations may be influenced by factors other than arterial BP, 
such as arterial stiffness (Pickering et al., 2005).  Further, the algorithm used to derive 
SBP and DBP is determined by the manufacturer and programmed into the device 
(Pickering et al., 2005). 
Ultrasonography 
 Measurement of arterial BP using ultrasonography requires a sphygmomanometer 
cuff, used to occlude arterial blood flow, and an ultrasound transmitter and receiver, used 
to detect arterial wall movement.  The cuff is initially inflated above SBP to occlude 
arterial blood flow while the ultrasound device is placed over the occluded artery.  As the 
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cuff is steadily deflated there is a noticeable movement of the arterial wall once the 
pressure of the cuff meets SBP which causes a Doppler phase shift in the reflected 
ultrasound (Pickering et al., 2005).  Just as the onset of arterial wall movement signifies 
SBP the point at which this movement begins to diminish signifies DBP (Pickering et al., 
2005).  Determination of arterial BP using ultrasonography is particularly useful for 
individuals with faint Korotkoff sounds and in infants and children (Pickering et al., 
2005; Elseed et al., 1973). 
Penaz/Wesseling Method  
 This method, developed by Penaz and Wesseling, involves the placement of a 
small pressure cuff around the finger.  Arterial size is determined, and pulsation within 
the finger is detected, by an infrared transmission plethysmograph located under the cuff 
(Langewouters et al., 1998).  The changes in arterial diameter detected by the 
plethysmograph feeds a servo-loop, which modulates cuff pressure to hold the artery in a 
constant-diameter partially opened state (Pickering et al., 2005).  The arterial size set-
point value of the servo-system was provided by the Physiocal criteria of Wesseling 
(Wesseling et al., 1995).  Oscillations in arterial pressure are measured via an electric 
gauge and recorded as an indirect measure of the intra-atrial pressure waveform 
(Langewouters et al., 1998; Pickering et al., 2005).  Further analysis by a pattern 
recognition program provides both systolic and diastolic pressure data per heart beat 
(Langewouters et al., 1998).  This method has been shown to result in measures that are 
lower than direct intra-arterial measures and this has been attributed to differences in the 
pressure gradients of the hand versus the brachial artery (Imholz et al., 1991). 
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Tonometry 
 Measurement of arterial BP using tonometry is based upon a principle that states 
when an artery is partially compressed or splinted against a bone, the resulting pulsations 
are proportional to the intra-arterial pressure changes (Pickering et al., 2005).  This 
technique continuously measures changes in arterial pressure through the cardiac cycle to 
determine the pulse pressure waveform.  During resting conditions the average SBP and 
DBP measurements determined using tonometry correspond well with intra-arterial 
measures (Sato et al., 1993).  This method is not without its limitations, most notably the 
position sensitivity of the probe over the artery.  As proper signal transduction requires 
the probe to be situated directly over the center of the artery this technique is very 
position dependent (Pickering et al., 2005).  Further, excessive hold-down forces may 
skew pressure waveforms, motion artifacts may infiltrate the data output, and the 
calibration of the tonometer requires the use of an external arterial BP measurement 
device (Wang et al., 2004). 
1.1.4 Pathophysiology of Hypertension 
   HT is a prominent risk factor for CVD, which is currently a leading cause of 
morbidity and mortality in Canadians of both sexes (Statistics Canada, 2009).  HT in 
adults is defined as having a resting SBP above 139 mmHg, and/or a resting DBP above 
89 mmHg (Chobanian et al., 2003), and afflicts over 4.6 million Canadians (Statistics 
Canada, 2009). This is in contrast to normal resting arterial BP, which as stated 
previously in 1.1.2 Arterial Blood Pressure Regulation is identified as <120/80 mmHg 
(Chobanian et al., 2003).  HT can be further subdivided into stages defined by ranges of 
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resting arterial BP.  Stage 1 HT is defined as a resting arterial BP within the range of 140-
159/90-99 mmHg, whereas stage 2 HT encompasses resting arterial BP above 160/100 
mmHg (Chobanian et al., 2003). Genetic and environmental factors, along with 
alterations in sex hormones with increasing age, have been implicated in the development 
of HT (Coylewright, 2008).  Although significant improvements in screening, prevention, 
and treatment have been made, HT remains a major health problem for Canadians. 
Types of Hypertension and their Characteristics 
 At the most general level HT can to divided into 2 categories: primary or 
secondary HT.  Primary HT is the most common and denotes HT of an unknown cause 
(Carretero & Oparil, 2000), whereas secondary HT is far less common and signifies HT 
due to a known pathophysiology (Chobanian et al., 2003).  Other HT sub-types include 
isolated systolic, resistant, malignant, and white-coat HT. 
 Primary Hypertension 
 Primary (essential, idiopathic) HT is characterized by elevations in resting arterial 
BP due to an unknown cause (Messerli et al., 2007; Carretero & Oparil, 2000).  This type 
of HT is the most common, constituting approximately 95% of all cases (Carretero & 
Oparil, 2000), and numerous lifestyle factors may accumulate to initiate this sustained 
rise in BP.  These factors, termed hypertensinogenic, are defined as substances or 
situations that tends to increase resting arterial BP and include aging, obesity, insulin 
resistance, excessive sodium intake, excessive alcohol intake, a sedentary lifestyle, 
excessive stress, low potassium intake, and/or low calcium intake (Sever & Poulter, 
1989; INTERSALT, 1988).  Further, these factors may interact with individually 
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inherited genetic traits resulting in modifications of resting arterial BP, which may lead to 
the onset of primary HT (Carretero & Oparil, 2000). 
 Secondary Hypertension 
 Secondary HT is defined as an elevated resting arterial BP due to a recognized 
underlying pathophysiology of the renal system, endocrine system, vascular system, 
lungs, and/or central nervous system (Chobanian et al., 2003).  As the underlying 
pathophysiology causing secondary HT is identifiable, this condition is often referred to 
as curable or reversible (Danielson & Dammstrom, 1981; Lewin et al., 1985).  Although 
much less common than primary HT, prevalence estimates of secondary HT range from 
approximately 5 to 10% (Berglund et al., 1976; Omura et al., 2004).  Notable causes of 
secondary HT involve endocrine disorders (Sica, 2008; Chiong et al., 2008), renovascular 
disorders (Ram et al., 1995; Chiong et al., 2008), adrenal disorders (Chiong et al., 2008), 
neurological disorders (Chiong et al., 2008), pharmacological side effects (Chiong et al., 
2008), and/or aortic diseases (Bhat et al, 2001; Chiong et al., 2008).  One must also 
consider the possible co-existence of multiple factors, as well as interactions between 
factors, when identifying the underlying pathophysiology of individuals with secondary 
HT. 
Hypertension Sub-Types 
Isolated Systolic Hypertension 
 Isolated systolic HT has been generally defined as having a SBP of ≥140 mmHg, 
with a DBP of ≤ 90 mmHg.  Early literature suggests that this type of HT predominantly 
affects the elderly, but more recent evidence indicates that isolated systolic HT is also the 
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predominant form of HT in adolescents and young adults (Franklin et al., 2001; Chiolero 
et al., 2007).  This is consistent with the statement that isolated systolic HT is the most 
prevalent form of primary HT when considering all cases (Izzo et al., 2000).   
 There is clear evidence to support the notion that controlling isolated systolic HT 
leads to reductions in mortality, incidence of cardiovascular events, and stroke (Garland 
et al., 1983; Curb et al., 1985).  Further, SBP has been shown to be more important than 
DBP in predicting cardiovascular morbidity and mortality (Rhutan et al., 1989; Kannel, 
1974).  The pathophysiology of isolated systolic HT can be divided into both structural 
and functional changes.  Structurally, isolated systolic HT may be caused by a decrease in 
arterial compliance through stiffening of the arteries leading to increased peripheral 
resistance and elevated resting arterial BP (Kannel et al., 1971; Beltran et al., 2001).  
Isolated systolic HT is also associated with increases in SNS activity (Grassi et al., 1999), 
which may lead to structural remodeling, further increasing peripheral resistance and/or 
altering vascular distensibility (Heagerty, 1997). 
Resistant Hypertension 
 Resistant HT is characterized by a persistent elevation in resting arterial BP, with 
failure to reach goal targets (e.g., arterial BP controlled to within the normal range), 
despite the concurrent use of at least 3 anti-hypertensive agents (See: 1.1.5 Treatment 
and Prevention of Elevated Blood Pressure below for details regarding 
pharmacological treatment of HT) of different classes (Chobanian et al., 2003; Calhoun et 
al., 2008).  Further, persons with controlled resting arterial BP via 4 or more anti-
hypertensive agents are also considered resistant to treatment (Calhoun et al., 2008).  Due 
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to factors such as poor adherence and under-treatment it is difficult to ascertain the 
precise prevalence of resistant HT independent of uncontrolled HT.  Nonetheless, large, 
diverse, well-designed control trials provide evidence that this type of HT is fairly 
common (Cushman et al., 2002).   
 The pathophysiology of resistant HT is multifaceted and may involve 
contributions from various sources.  More specifically, lifestyle factors such as obesity, 
alcohol intake, and sodium consumption along with secondary causes including 
obstructive sleep apnea, pheochromocytoma, primary aldosteronism, Cushing’s 
syndrome, renal artery stenosis, renal parenchymal disease, hyperparathyroidism, aortic 
coarctation, and intracranial tumors have been implicated in the pathophysiology of 
resistant HT (Calhoun et al., 2008).  A common thread between these factors is an 
increase in SNS activity, possibly due to excess aldosterone levels (Wray & Supiano, 
2010; Gaddam et al., 2008), which has been proposed as a primary underlying 
mechanism of resistant HT (Calhoun et al., 2008; Tsioufis et al., 2011).  
Malignant Hypertension 
 Malignant HT is defined by a sudden, large rise in arterial BP combined with a 
malignant vascular injury (Fleming, 2000).  Pathological changes underlying malignant 
HT include endothelial injury, arteriolar modifications, and glomerular ischemia 
(Ruggenenti & Remuzzi, 1996).  More specifically, kidneys often show cortical and sub-
capsular hemorrhaging, while arteries may show proliferative endarteritis, necrosis, and 
nucleoid changes, and interlobular arteries may narrow due to fibrin, intimal hyperplasia, 
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and collagen deposits (Ruggenenti & Remuzzi, 1996).  Taken together these factors may 
decrease renal tissue perfusion and lead to local ischemia.   
Presentation of this disorder can occur independently, but it often complicates 
concomitant primary or secondary HT (Kitiyakara & Guzman, 1998).  Although 
uncommon, this type of HT affects approximately 1% of those individuals already 
experiencing HT and is more prevalent in younger adults (Kitiyakara & Guzman, 1998).  
Further, the incidence of malignant HT is twice as high in males as compared to females 
(Kitiyakara & Guzman, 1998).  Early investigations of malignant hypertension indicated 
poor prognosis and low patient survival rates, often due to uraemia (Kincaid-Smith et al., 
1958; Leishman, 1959), but advancements in pharmacological treatments have 
significantly improved patient outcomes (Gudbrandsson et al., 1979; Gonzalez et al., 
2010). 
 White Coat Hypertension 
 White coat HT is a unique transient situation in which individuals experience 
increased resting arterial BP readings in a clinical setting while maintaining arterial BP 
levels within normal ranges during regular daily living (Verdecchia et al., 2001).  This 
white coat effect can be determined by comparing the average resting arterial BP 
measurements taken in a clinical setting to average daytime ambulatory BP readings.  
There is still much debate in the literature regarding potential cardiovascular risks 
associated with white coat HT.  Long-term follow up studies suggest an increased 
incidence of cardiovascular events and/or disease progression in individuals with white 
coat HT relative to their normotensive peers (Gustavsen et al., 2003; Mancia et al., 2009), 
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while other investigations dismiss any significant risks associated with white coat HT 
(Grosse et al., 1993; Cohen & Townsend, 2010).  Nonetheless, it appears that individuals 
who exhibit white coat HT may be more disposed to developing sustained HT with age 
(Mancia et al., 2009). 
1.1.5 Treatment and Prevention of Elevated Blood Pressure 
 The primary goal of reducing resting arterial BP is to decrease morbidity and 
mortality related to cardiovascular and renal disease (Chobanian et al., 2003).  Primary 
prevention and treatment recommendations for HT can be divided into two general areas: 
lifestyle modifications and pharmacological therapies.  As most individuals with HT 
experience reductions of DBP concomitant to reductions in SBP the primary focus of 
these therapies is reaching target SBP levels (Chobanian et al., 2003).  The treatment goal 
for individuals with HT, but without co-morbidities such as heart failure, diabetes, or 
chronic kidney disease, is to lower resting arterial BP below 140/90 mmHg (Chobanian et 
al., 2003).  Further, for individuals with prehypertension (BP 120-129/80-89 mmHg), and 
no other co-morbidities, it is recommended that resting arterial BP should be reduced to 
within the normal range (<120/80 mmHg) through lifestyle modifications (described 
below) to prevent a progressive rise in resting arterial BP (Chobanian et al., 2003).  
Lifestyle Modifications  
 As mentioned above, lifestyle modifications (dietary and physical activity) are 
cornerstones of prevention and treatment programs for those with, or at risk for, HT.  
Changes in the composition of an individual’s diet and/or physical activity patterns are 
the first and most common suggestions for HT management (Chobanian et al., 2003; 
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Pescatello et al., 2004).  Modifications that focus on HT management through 
consumption of healthier foods and regular physical activity have been shown to be 
effective in lower the resting arterial BP of multiple populations (Appel et al., 1997; 
Roberts et al., 2002; Blumenthal et al., 2010).  The hypotensive effects of improved 
dietary food composition can be augmented through decreased alcohol intake, limited 
sodium consumption, and the maintenance of a healthy body weight (Chobanian et al., 
2003).  Further, adhering to the guidelines put forth in the Dietary Approaches to Stop 
Hypertension (DASH), which combines dietary modifications and physical activity, may 
provide added hypotensive benefits (Appel et al., 1997; Chobanian et al., 2003). 
 The DASH guidelines emphasize the consumption of fruits, vegetables, and low-
fat dairy products while also including whole grains, fish, poultry, and nuts while limiting 
consumption of red meat, sweets and sugary beverages, total fat, saturated fat, and 
cholesterol (Appel et al., 1997).  Though all individuals do not respond to the DASH diet 
to the same degree, responses are often equivalent to those observed through 
pharmacological treatment (Chobanian et al., 2003).  The DASH diet itself has been 
shown to significantly reduce SBP, but there is support for additive effects of restricted 
sodium consumption, which may provide a more potent hypotensive response (Vollmer 
et al., 2001; Sacks et al., 2001).  Though DASH non-responders may not experience the 
desired decreases in resting arterial BP, they may experience indirect health benefits, 
such as improved body composition, by adhering to healthier dietary food intakes.  
As mentioned above, increased physical activity is an important component of the 
lifestyle modifications recommended for the prevention and treatment HT. The specific 
effects of chronic exercise training, as well as those of acute exercise, on resting arterial 
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BP, are discussed in detail below in the section entitled: Exercise and Arterial Blood 
Pressure. 
Pharmacological Treatment 
 When lifestyle modifications and exercise interventions fail to elicit the desired 
decreases in resting arterial BP pharmacological treatment is recommended.  There are 
different classes of pharmacologic substances that can be used alone or in combination to 
treat elevated resting arterial BP.  The most common classes of pharmacological 
substances used to treat elevated BP include: diuretics, which increase water excretion 
from the body through their actions on the renal tubule, ACE inhibitors, which block the 
conversion of angiotensin I to angiotensin II, angiotensin receptor blockers, which block 
the activation of angiotensin II receptors, β-blockers, which block the binding of 
catecholamines to beta receptors in the heart and smooth muscle, and calcium channel 
blockers, which inhibit the movement of Ca2+ across the membrane of the smooth 
muscle.  The site of action of each of these substances may differ, but the desired 
outcome is the same: decreased resting BP through modulation of Q or TPR in an effort 
to decrease the morbidity and mortality associated with HT. 
Exercise and Arterial Blood Pressure  
 Physical activity modification is often used concurrently with dietary changes in 
treating and preventing HT.  Physical activity can be sub-divided into aerobic-based 
exercise modalities, such as walking and cycling, and resistance-based exercise 
modalities, such as lifting weights.  Further, resistance training can be divided into 
dynamic resistance or static (isometric) resistance exercise, as there is growing evidence 
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for the efficacy of isometric training in resting arterial BP regulation (McGowan et al., 
2006; McGowan et al., 2007a; McGowan et al., 2007b; Taylor et al., 2003; Millar et al., 
2009; Badrov et al., 2013a; Badrov et al., 2013b).  It is important to note that 
quantification of exercise includes both an intensity and duration component.  Specific 
exercise recommendations for hypertensive individuals have been developed by the 
American College of Sports Medicine (ACSM) and include 30-to-60 minutes of 
moderate (40 to 60% of an individual’s HR reserve) aerobic activity performed 3 to 7 
days per week (Thompson, 2010).  Though these guidelines focus on aerobic exercise, 
resistance training is recommended as an adjunct that can be performed 2 to 3 times per 
week (Pescatello et al., 2004). 
  Chronic Aerobic Exercise  
 Literature regarding the effects of aerobic based exercise training protocols on 
resting BP is plentiful and consistently reports decreases of 5-7 mmHg in resting SBP and 
DBP (Halbert et al., 1997; Cade et al., 1984; Kiyonaga et al., 1985).  To better understand 
the dose-response relationship of aerobic training and BP reduction we can examine the 
frequency and intensity of the exercise used in these investigations.  A meta-analysis of 
aerobic-based interventions on BP modulation reveals a frequency range of 2.5 to 7 
exercise sessions per week in the published literature (Cleroux et al., 1999).  Though 
there may be a positive correlation between exercise frequency and resting arterial BP 
reduction it has been noted that approximately 75% of the hypotensive benefits of aerobic 
exercise garnered on a 7-session per week protocol can be achieved in 3 sessions per 
week (Nelson et al., 1986).  With regards to exercise intensity, although multiple meta-
analyses suggest exercise intensity does not influence the magnitude of post-training 
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resting arterial BP changes, others provide evidence to suggest that moderate, rather than 
high, intensity exercise may elicit the greater hypotensive response (Pescatello et al., 
2004; Cleroux et al., 1999).  Perhaps the most notable interpretation is that the 
hypotensive effects of aerobic exercise do not depend on increases in maximal aerobic 
capacity, but the effects do correlate well with an individual’s level of activity with a 
higher activity level evoking a more hypotensive response (Cleroux et al., 1999). 
 The underlying mechanisms driving the hypotensive training response to aerobic 
exercise remain unclear.  It is currently believed that resting arterial BP alterations due to 
aerobic training are more likely a derivative of changes in TPR rather than Q (Pescatello 
et al., 2005).  Moreover, structural, neural and/or hormonal modifications may also be 
underlying mechanisms.  Structural changes, including vascular remodeling and 
angiogenesis, have been suggested as causal mechanisms for the resting arterial BP 
lowering effects of aerobic exercise training (Pescatello et al., 2005).  Aerobic exercise 
leads to a reduction in pre-capillary vascular resistance (Sexton & Laughlan, 1994), 
which may decrease TPR and, therefore, resting arterial BP (Pescatello et al., 2005).  
There is also indirect evidence to suggest that chronic aerobic exercise training may 
reduce SNS activity (Pescatello et al., 2005), and thus resting arterial BP.  Aerobic 
training may also modulate resting arterial BP through alterations in vascular 
responsiveness.  A collection of animal studies has shown that aerobic exercise training 
reduces vascular responsiveness to the vasoconstrictors NE and ET-1 (Chen et al., 1994; 
Wiegman et al., 1981; Laughlin et al., 2001).  Genetic interactions have been estimated to 
account for approximately 17% of the reduction in resting arterial BP following aerobic 
exercise training although precise mechanisms remain unclear (Rice et al., 2002). 
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Acute Aerobic Exercise 
 During an acute bout of aerobic exercise arterial BP is modulated predominantly 
to meet the increased demands of the working muscles.  Initially there is an increase in 
SBP to reach the necessary tissue perfusion required to maintain the increase in muscular 
metabolism (MacDonald, 2002).  The observed arterial BP increase occurs due to 
increases in both HR and Q via reductions in PNS activation and increases in SNS 
activation (MacDonald, 2002).  As described previously, the vasculature supplying the 
working muscles progressively vasodilates to provide adequate tissue perfusion, which 
effectively reduces TPR.  After the initial peak in SBP there is a gradual reduction to 
normalized levels of approximately 140 – 160 mmHg as the contractile state of the 
vasculature, and TPR, becomes stabilized (McArdle et al., 2001). 
 There are also characteristic arterial BP changes during the periods post-exercise, 
most notably being post-exercise hypotension (PEH).  Immediately following an aerobic 
exercise bout there is a decrease in arterial BP (Kenney & Seals, 1993).  This 
phenomenon has been observed up to 22h post-exercise and is proportional to pre-
exercise resting arterial BP (Rondon et al., 2002; Kenney & Seals, 1993), such that 
individuals with greater pre-exercise resting arterial BP will generally see a larger PEH 
response (Kenney & Seals, 1993).  The exact mechanisms underlying PEH remain 
unclear, though there have been two main hypotheses proposed.  The first hypothesis is 
that acute aerobic exercise decreases SNS outflow, though how this occurs remains 
unclear (Floras et al., 1989; Halliwill et al., 1996).  The second hypothesis involves 
alterations in vascular responsiveness via decreased transduction of SNS outflow and/or 
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increased release of vasodilator substances due to increases blood flow and/or muscular 
work (Pescatello et al., 2005). 
  Chronic Resistance Exercise 
 Unlike aerobic training, research regarding the benefits of resistance training 
programs for resting arterial BP control is much less clear.  An early meta-analysis of 
studies conducted between 1966 and 1998 indicated an overall decrease of approximately 
3 mmHg for both SBP and DBP due to resistance training (Kelly & Kelly, 2000).  Similar 
results were observed in a meta-analysis spanning 1996 to 2003 with average resting 
arterial BP reductions of 3.2 mmHg systolic and 3.5 mmHg diastolic (Cornelissen & 
Fagard, 2005), and in its updated version, which expanded the data set to 2012 
(Cornelissen & Smart, 2013).  Although reductions of this magnitude seem insignificant 
it should be noted that decreasing SBP by merely 3 mmHg yields significant reductions 
in cardiovascular morbidity and mortality (Verdecchia, 2000).  As such, in 1990 the 
ACSM recognized resistance training as a beneficial component of a comprehensive 
fitness program for healthy adults. 
  Acute Resistance Exercise 
 An acute bout of resistance exercise induces a sudden, drastic increase in both 
SBP and DBP of up to 400/200 mmHg, respectively (MacDougall et al., 1985).  This 
response is due to the high intramuscular pressures induced by resistance exercise, which 
compresses the vasculature supply blood to the working muscles (Mayo et al., 1999).  
This compression increases TPR and may cause blood flow occlusion to the working 
muscle (Mayo et al., 1999).  In an effort to prevent ischemia and increase muscular 
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perfusion the activity of the SNS is increased (HR & cardiac contractility), increasing 
arterial BP (MacDougall et al., 1985; Mayo et al., 1999).  The arterial BP response to 
acute resistance exercise is proportional to the muscle mass activated and muscular work 
performed (MacDougall et al., 1985).  Unlike aerobic exercise, the occurrence of PEH 
with resistance training remains equivocal.  If PEH is observed after resistance exercise it 
may simply be due to reperfusion of previously working muscles experiencing increased 
intramuscular compression (MacDougall et al., 1985; MacDonald, 2002). 
  Chronic Isometric Hand-Grip Exercise 
 The role of isometric hand-grip (IHG) exercise in the modulation of resting 
arterial BP has received increasing attention over the past decade.  Recently endorsed by 
the American Heart Association as an alternative BP-lowering treatment, this exercise 
modality is a novel form of static-resistance training where individuals perform multiple, 
timed, sustained contractions on a programmed handgrip dynamometer at a set 
percentage of their maximum voluntary effort (Brook et al., 2013).  IHG training has 
shown to markedly reduce both resting SBP and DBP in men and women with and 
without HT, including those currently on medication(s) to treat their HT, and those who 
regularly exercise (McGowan et al., 2006; McGowan et al., 2007a; McGowan et al., 
2007b; Millar et al., 2007, Millar et al., 2008; Peters et al., 2006; Taylor et al., 2003; 
Wiley et al., 1992; Ray & Carrasco, 2000; Badrov et al., 2013a; Badrov et al., 2013b).  
Collectively, these studies employed IHG training protocols of a wide range of 
frequencies (3 to 5 sessions per week), durations (45-second to 2-minute contractions), 
intensities (30 to 50% of MVC) and intervention lengths (5- to 10-weeks). Recent meta-
analyses concluded that resting arterial BP reductions with IHG training appear similar 
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to, if not greater than, those elicited by aerobic exercise training (Kelley & Kelley, 2010; 
Cornelissen & Fagard, 2005; Cornelissen & Smart, 2013).  
 Older females with normal resting arterial BP (<120/80 mmHg) appear to respond 
to IHG with greater post-training (8 weeks) resting arterial BP reductions than age-
matched males (Millar et al., 2008).  Further, preliminary results from our research 
laboratory (Physical Activity and Cardiovascular Research Laboratory, Department of 
Kinesiology, University of Windsor) suggest that in contrast to the older cohort, sex 
differences do not exist in response to IHG training in young, healthy normotensive men 
and women (Hanik et al., 2012).  Unknown is whether older normotensive males and 
females respond differently, via neurovascular responses such as HR, BP, smooth muscle 
function, and/or HR variability, to the acute exercise stimulus (e.g., an single, acute bout 
of IHG exercise).  Thus, identifying possible differences in the neurovascular response to 
IHG exercise may elucidate the mechanism underlying the observed variation in response 
between sexes in older populations. 
 The underlying mechanisms regulating chronic resting arterial BP responses to 
IHG exercise remain equivocal.  Furthermore, it is still unclear whether IHG training 
elicits a systemic vascular effect, as the untrained limbs are often not analyzed.  
McGowan and colleagues (2007b) have shown that IHG training in medicated 
hypertensive individuals does not change endothelial-dependent vasodilation in the 
untrained limb, but further study is warranted.  Nonetheless, current hypothesized 
mechanisms of post-IHG training resting arterial BP reductions include improvements in 
ANS function, improved NȮ-dependent vascular function (McGowan et al., 2006; 
McGowan et al., 2007a; McGowan et al., 2007b; Taylor et al., 2003; Millar et al., 2009; 
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Badrov et al., 2013), and/or reductions in oxidative stress (Peters et al., 2006).  It is 
conceivable that the mechanisms are multi-faceted, and may differ among individual 
subjects and populations (e.g., old versus young, medicated versus un-medicated HT). 
 Acute Isometric Hand-Grip Exercise 
 The underlying mechanisms regulating the cardiovascular effects of a single, 
acute bout of IHG exercise may or may not be similar to that observed during chronic 
IHG exercise.  Observations immediately after an IHG bout indicate no changes in HR 
and an increase in arterial BP due to vascular compression in the working arm, which 
increases TPR (Araujo et al., 2011).  Further, elevated arterial BP returned to near resting 
values after the first minute of post-exercise rest, possibly indicating the progression of 
PEH (Araujo et al., 2011).   PEH has been observed 1 minute after a single IHG 
contraction at 35% MVC in young healthy subjects (Stewart et al., 2007).  Likewise, PEH 
was also observed 5 minutes post IHG exercise (four 2-minute contractions at 30% MVC 
with 1 minute rest intervals) in older individuals (Millar et al., 2009).  There is also 
indirect evidence of improved cardiac autonomic modulation, possibly due to enhanced 
vagal activation, after an acute bout of IHG exercise (Millar et al., 2009).  The 
mechanisms regulating acute arterial BP responses to IHG exercise may provide insight 
into chronic adaptations and/or have clinical implications themselves. 
1.2 Reactive Oxygen Species, Oxidative Stress and Arterial Blood Pressure 
 Reactive oxygen species (ROS), also known as oxidative free radicals, have been 
implicated in the pathophysiology of HT and have garnered increasing investigation 
(Touyz, 2004; Datla & Griendling, 2010).  ROS refer to atoms, molecules or ions that 
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have unpaired electrons in their outer valence shells (Chen et al., 2012).  This 
characteristic makes ROS highly reactive within biological systems, allowing them to 
react with adjacent molecules such as proteins, lipids, carbohydrates and nucleic acids 
(Chen et al., 2012).  ROS are produced through biochemical reactions that reduce the 
state of O2 (Hancock et al., 2001).  The reduction of O2 produces a number of ROS, the 
most common of these including superoxide radicals (Ȯ2), hydrogen peroxide (H2O2), 
hydroxyl radicals (OḢ), and peroxynitrite (ONOO-) (Hancock et al., 2001).   
 Endogenous sources of ROS production include: the mitochondrial electron 
transport chain, xanthine oxidase, cyclooxygenase, lipoxygenase, NȮ synthase, heme 
oxygenases, peroxidases, hemoproteins such as heme and hematin, and NADPH oxidases 
(Pennathur & Heinecke, 2007; Kojda et al., 1999).  The most important of these ROS 
sources is suggested to be the NADPH oxidase enzyme that, using electrons supplied by 
NADPH, catalyzes the reaction of O2 to form Ȯ2 (Hancock et al., 2001).  The reduction of 
O2 by one electron produces Ȯ2, which is highly reactive due to the unpaired electron in 
the outer valence shell (Sies, 1997; Chen et al., 2012).  Likewise, O2 can be reduced to 
water (H2O), but the intermediate steps include the formation of H2O2 and ȮH (Sies, 
1997).  These molecules can induce pathophysiological changes to lipids, proteins and 
DNA, by altering the structure and function of these cells and tissues (Bandyopadhyay et 
al., 1999). 
 Evidence suggests that ROS are not only negative by-products of substrate 
metabolism, but that they may also play a role in cellular signaling (Hancock et al., 
2001).  The differing roles of ROS, as signaling molecules or destructive metabolic by-
products, may depend on the concentration of ROS present (Thannickal et al., 2000).  
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ROS are continuously produced at relatively low rates during rest, but their synthesis 
markedly increases during exercise (Reid & Durham, 2002; Bejma & Ji, 1999).  At 
relatively low concentrations ROS function as signaling molecules, which maintain 
vascular integrity through modulation of smooth muscle contraction and endothelial 
function (Touyz et al., 2003).  In contrast, chronic elevations in ROS production have 
been linked to endothelial dysfunction, lipid peroxidation, smooth muscle cell growth, 
inflammation, monocyte invasion, increased contractility and increased extracellular 
matrix protein deposition (Diep et al., 2002; Taniyama & Griendling, 2003). 
 The term “oxidative stress” refers to a state of imbalance between the production 
of ROS and the removal and/or stabilization of these substances by cellular antioxidant 
defense systems (Rodriguez-Manas et al., 2009).  An antioxidant refers to any molecule 
capable of neutralizing or stabilizing a free radical before they can damage cells and 
tissues (Chen et al., 2012).  These substances can be produced endogenously within the 
body, or consumed through exogenous dietary sources.  The most prominent endogenous 
antioxidants include superoxide dismutase (SOD), glutathione peroxidase (GPx) and 
catalase (Paravicini & Touyz, 2008).  SOD catalyzes the dismutation of Ȯ2 into H2O2 
(Chen et al., 2012).  H2O2 can then be converted into H2O and O2 via GPx or catalase.  
GPx consumes reduced glutathione and convert H2O2 into H2O, while catalase facilitates 
the conversion of H2O2 into H2O and O2 (Chen et al., 2012; Paravicini & Touyz, 2008).  
The balance between oxidants and antioxidants may be key in the pathophysiology of 
many chronic diseases, and accordingly, oxidative stress has been implicated in HT as 
well as atherosclerosis, vascular disease, diabetes, and aging (Harman, 1956; Pannathur 
& Heinecke, 2007; Touyz, 2004; Higashi et al., 2002). 
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Effects of Exercise on Reactive Oxygen Species and Blood Pressure Regulation 
 As alluded to above, oxidative stress is thought to play an important role in 
arterial BP regulation and the underlying pathophysiology of HT (Nakazono et al., 1991; 
Ferroni et al., 2006; Harrison et al., 2007), and its reduction has been implicated in the 
resting arterial BP reductions observed with IHG training (Peters et al., 2006). 
When the endogenous antioxidant capacity becomes saturated continued 
production of ROS induces a state of oxidative stress.  ROS produced in the neural, renal, 
and vascular systems are implicated in the pathophysiological signaling that leads to the 
development of HT (Datla & Griendling, 2010).  Further, increased bioavailability of 
ROS can promote endothelial dysfunction through reductions in NȮ bioavailability 
(Pennathur & Heinecke, 2007), upregulation of the RAAS (Diep et al., 2002), increases 
in systemic inflammation (Diep et al., 2002), and vascular remodeling (Shiffrin, 2004).  
These outcomes can individually and collectively contribute to the sustained elevations in 
resting arterial BP associated with HT.  
 The relative importance of NȮ to the health and function of endothelium, and its 
reduced bioavailability due to ROS, has prompted increasing investigation into the 
implications for HT development.  The ROS Ȯ2 is able to react with NȮ to produce the 
highly reactive ONOO- (Hancock et al., 2001).  As the rate of reaction between Ȯ2 and 
NȮ is far greater than the rate of reaction between Ȯ2 and SOD, an endogenous 
antioxidant capable of neutralizing its activity, Ȯ2 will more readily react with NȮ (Chen 
et al., 2012).  As NȮ serves an important role in the health and contractile state of the 
smooth muscle (Sarkar et al., 1996; Moncada et al., 1991), a decrease in its 
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bioavailability may produce negative consequences to vascular health, impaired 
vasodilation, and increased resting arterial BP. 
 ROS may further influence the bioavailability of NȮ through its actions on the 
critical eNOS cofactor tetrahydrobiopterin (BH4).  When reactive Ȯ2 is produced from 
vascular NAD(P)H oxidase enzymes it oxidizes BH4 and reduces the bioavailability of 
this critical cofactor (Landmesser et al., 2003).  In the presence of reduced amounts of 
BH4, and increased amounts of oxidized BH4, the stimulation of eNOS produces large 
amounts of Ȯ2 (Bevers et al., 2006; Landmesser et al., 2003).  The negative consequences 
of this cycle, namely chronic reductions in NȮ and increases in Ȯ2, may be critical in the 
progression and underlying pathophysiology of HT.   
Reactive Oxygen Species Production and Acute Exercise 
 In general, acute exercise leads to increased O2 consumption and an increase in 
the production of ROS, such as Ȯ2, from oxidative metabolism (Bejma & Ji, 1999).  With 
respect to aerobic exercise, transient increases in ROS production and consequent 
oxidative stress, as indicated by an increased ratio of oxidized glutathione-to-total whole-
blood glutathione ratio (GSSG:TGSH), have been observed following an acute bout of 
aerobic exercise (Bloomer et al., 2005).  Participants cycled at 70% of VO2max for 30 
minutes and blood was drawn for analysis pre, post, 1h-post, 6h-post, and 24h-post 
exercise.  The GSSG:TGSH ratio was increased immediately following exercise, but 
returned to baseline at 1h-post exercise.  The authors hypothesized that an acute increase 
in oxidative modification of TGSH occurs immediately post-exercise, increasing 
production of GSSG, but the rapid action of glutathione reductase catalyzes the 
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conversion of GSSG to reduced glutathione (Bloomer et al., 2005).  It is possible that the 
observed oxidative stress in this study is due to increased Ȯ2 bioavailability.  To 
neutralize reactive Ȯ2 it can be converted to H2O2 by the enzyme SOD (Gohil et al., 
1988).  H2O2 formed by this reaction is then neutralized by the actions of the enzyme 
glutathione peroxidase, which converts H2O2 to H2O, but in the process produces GSSG 
(Gohil et al., 1988).  The observation of increased oxidative stress after acute aerobic 
exercise of differing intensities (i.e.: exhaustive, prolonged) and modalities (i.e.: running, 
cycling) has been repeatedly shown in the literature (Alessio et al., 2000; Sastre et al., 
1992; Gohil et al., 1988). 
 Acute resistant exercise also augments ROS production, possibly leading to 
oxidative stress and the associated negative consequences.  A circuit of resistance 
exercise (10 exercises, 9 repetitions, at 75% of 1 repetition maximum (RM)) acutely 
increased plasma antioxidant concentrations (α-tocopherol, γ-tocopherol, β-carotene, 
lycopene), but this was not sufficient to prevent augmented lipid peroxidation 
immediately post-exercise (Ramel et al., 2004).  Likewise, a resistance training circuit (2 
circuits, 8 exercises, 3 sets of 10 repetitions at 100% of 10 RM) significantly increased 
the concentration of malonyldialdehyde (MDA) immediately post-exercise.  MDA is a 
biomarker of free radical interaction with the lipids of cell membranes.  The observation 
that acute resistance exercise elicits significant increases in the concentration of MDA 
has been shown repeatedly (Hoffman et al., 2007; Heunks et al., 1999).  There is also 
evidence of significant increases in xanthine oxidases, which can generate Ȯ2, 
immediately post-resistance exercise (Heunks et al., 1999).  As resistance exercise does 
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not tax aerobic metabolism heavily future study should attempt to elucidate possible 
differences between acute aerobic and resistance ROS production. 
This observation is not unique to aerobic or resistance exercise modalities and has 
also been observed following an acute bout of IHG.  For example, in work conducted by 
Alessio et al. (2000), participants performed 45 second contractions at 50% MVC with 45 
second rest periods until the accumulated time was equal to the time it took to complete a 
VO2max test (approximately 15 minutes) (Alessio et al., 2000).  Increases in lipid 
hydroperoxides, an indicator of increased oxidative stress, were observed immediately 
post-exercise (Alessio et al., 2000).  These findings may be due to increased post-exercise 
bioavailability of Ȯ2 generated via: metabolite-induced production, exercise-induced 
temperature rise, mechanical-stress induced inflammation and/or ischemia-reperfusion 
(IR) induced production (Alessio et al., 2000; Holecek et al., 2004).  Ȯ2, if not 
neutralized, can be reduced or dismutated to H2O2, which can be further reduced by iron 
to produce ȮH, a free radical capable of peroxidation and lipid hydroperoxide production 
(Girotti, 1998). 
Work by McGowan et al. (2006) supports the observation of increased oxidative 
stress following an acute IHG bout.  Investigators observed post-IHG bout reductions in 
NȮ-dependent vasodilation in the brachial artery of the exercised limb (an indirect 
indication of increased oxidative stress) immediately following a bout of IHG (4x2-
minute unilateral contractions at 30% MVC with 4-minutes rest between) in an older 
population of medicated hypertensives, which is suggestive of reduced local NȮ 
bioavailability.  As Ȯ2 reacts rapidly with NȮ it is plausible that acute IHG exercise 
M.H.K. Thesis – J. Seifarth University of Windsor – Applied Human Performance 
	   39	  
augments Ȯ2 production, reducing NȮ bioavailability, inhibiting NȮ-dependent 
vasodilation. 
ROS Production and Chronic Exercise 
Most importantly, while a single bout of aerobic or IHG exercise acutely 
increases ROS production and oxidative stress, this effect is transient, and chronic 
exposure to either stimulus leads to adaptation and an increased basal antioxidant 
capacity (Peters et al., 2006; Miyazaki et al., 2001).   
Although the acute effects of augmented ROS production due to aerobic exercise 
may be interpreted as detrimental to health, they appear to serve a beneficial long-term 
purpose.  For example, chronic aerobic exercise training (i.e., repetitive exposure to acute 
bouts) leads to lower levels of oxidative damage after an intense exercise bout due to 
upregulation of antioxidant enzymes such as SOD, GPx, and glutamylcysteine synthase 
(Salminen & Vihko, 1983).  Likewise, increased SOD activity in response to aerobic 
training has been shown repeatedly in animal studies of various durations, intensities, and 
lengths (Higuchi et al., 1985; Powers et al., 1994; Leeuwenburgh et al., 1997).  If chronic 
aerobic exercise increases the endogenous antioxidant capacity of the system it could 
neutralize greater concentrations of ROS, such as Ȯ2, preventing the negative effects of 
oxidative stress (i.e.: reduced NȮ bioavailability) from negatively effecting arterial BP. 
As with aerobic training, ROS produced during acute IHG bouts may also confer 
long-term benefits.  It has been shown that, following 6 weeks of IHG training (3 
sessions per week, four total 45s contractions at 50% MVC, bilaterally, with 1 minute 
recovery between intervals), there is a marked increase in the resting TGSH:GSSG, an 
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indication of increased antioxidant capacity (Peters et al., 2006).  This work was 
supported by McGowan and colleagues who observed, in the group of participants with 
hypertension described above, an improvement in NȮ-dependent function of the brachial 
artery at rest (McGowan et al., 2006; McGowan et al., 2007a; McGowan et al., 2007b), 
which is suggestive of an increased basal antioxidant capacity.  Further, there is evidence 
to suggest that IHG training results in improved basal NȮ-dependent resistance vessel 
function (McGowan et al., 2007a; Badrov et al., 2013).  Increased antioxidant capacity 
through repeated exposures to the IHG stimulus may provide a greater capacity to 
neutralize future increases in free radical production, reduce the incidence and severity of 
oxidative stress, improve basal NȮ-dependent dilation supporting improved resistance 
vessel function, leading to resting arterial BP reduction. It is important to note, however, 
that post-bout attenuation in vascular function (FMD) was unchanged with 8-weeks of 
IHG training, suggesting that although basal function is improved with chronic exposure 
to the IHG stimulus, there is a lack of adaptation in stress-induced ROS antioxidant 
buffering capacity (McGowan et al., 2007a).   
The observed improvements in NȮ-dependent vasodilation may be due to 
increased basal antioxidant concentrations.  As stated previously, Ȯ2 reacts rapidly with 
NȮ reducing its bioavailability and inhibiting NȮ-dependent vasodilation.  Increased 
basal antioxidant action would better ameliorate the effects of elevated ROS production 
preserving NȮ for its role in resistance vessel function and arterial BP regulation.  The 
IHG studies to date have been underpowered to detect sex-based differences in the 
vascular responses to acute IHG and/or IHG training, including oxidative stress and 
antioxidant capacity, if they do exist.  
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1.3 Ischemia-Reperfusion 
 As mentioned in the above section entitled: Reactive Oxygen Species 
Production and Acute Exercise, IR is mechanism of ROS production.  IR refers to the 
sequence of events whereby the blood supply to cells and tissues is restricted for a period 
of time, inhibiting the supply of nutrients required for cellular metabolism, followed by 
reintroduction of the blood supply.  IR can occur due to trauma, such as during 
myocardial infarction or stroke (Dorweiler et al., 2007), but also due to high 
intramuscular pressures experienced during some exercise modalities, such as IHG 
exercise at 30% MVC or greater (Sadamoto et al., 1983; Sakakibara & Honda, 1990).  
This response is due to the high intramuscular pressures induced by resistance exercise, 
which compresses the vasculature supplying blood to the working muscles, increasing 
TPR, which may cause occlusion of blood flow (Mayo et al., 1999).  Occlusion of blood 
flow is known to augment the production of ROS, which can induce a state of oxidative 
stress (Kloner et al., 1989).  A constant onslaught of oxidative stress would plausibly lead 
to a multitude of negative effects, but as the above described chronic exercise training 
suggests, there may be a long-term benefit to repeated acute exposures. 
 Exposure to ischemic conditions can increase antioxidant concentrations, which 
may evoke an adaptive response and protection during subsequent exposure to oxidative 
stress (Hoshida et al., 1993; Powers et al., 1998).  An adaptive response refers to the 
ability of an organism to better defend against the damaging effects of a toxic agent after 
previous exposure to a lesser dose (Crawford & Davies, 1994).  Exposure of various cell 
cultures to oxidative stress evokes an adaptive response which renders them much more 
resistant to subsequently higher doses (Spitz et al., 1987; Laval, 1988; Lu et al., 1993).  
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Further, it has also been shown that aerobic exercise training (running for 1h/day with 
increasing speed and gradient over the first 10-weeks to 35m/min at 15% incline, 5 
days/week, for 18 weeks), which, as mentioned previously, acutely augments ROS 
production, can lead to adaptations that decrease post-exercise lipid peroxidation relative 
to sedentary controls (Alessio & Goldfarb, 1988).  Lipid peroxidation is a frequently 
measured marker of increased ROS production and oxidative stress.  Decreased post-
exercise lipid peroxidation indicates a greater basal antioxidant capacity, capable of 
neutralizing augmented ROS production.  Lastly, running on a treadmill for 60 minutes 
per day at 5m/min at 15% incline, 5 days per week, over a 10-12 week training period has 
been shown to restore diminished BH4 in older rats, improving NȮ-dependent 
vasodilation within the arterioles (Sindler et al., 2009).  Consistent evidence provides 
support for the notion that transient exposure to oxidative stress, be it through exercise 
and/or IR, may evoke an adaptive response leading to an increased basal antioxidant 
capacity.   
 IHG Exercise and Ischemia Reperfusion 
 Acute exposure to increased ROS via IR may be the mechanism underlying the 
observed positive adaptations due to IHG exercise that improve basal NȮ-dependent 
dilation and resistance vessel function while also lowering resting arterial BP.  IHG 
performed at ≥30% MVC progressively reduces forearm blood flow until total occlusion 
occurs at about 70 % MVC (Sakakibara & Honda, 1990).  As blood flow to the working 
tissues is decreased proportional to force during IHG exercise (Sakakibara & Honda, 
1990; Sejersted et al., 1984), and reactive hyperemia is increased during the recovery 
phase proportional to exercise intensity (Kagaya & Homma, 1997), it is possible that IR 
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is an underlying mechanism of the resting arterial BP reductions observed following 8 
weeks of thrice weekly, 30% MVC IHG training.  Increased antioxidant capacity may 
allow for greater neutralization of Ȯ2 leading to a greater bioavailability of NȮ, 
improving resistance vessel function and NȮ-dependent vasodilation.  If the resting 
arterial BP reductions from IHG exercise could be replicated using a simple IR protocol, 
one could quantify the stimulus and isolate IR as a causal mechanism.  Furthermore, sex-
specific differences in the resting arterial BP response to IR may provide insight into the 
observed sex differences in the resting arterial BP response to IHG training in older 
populations. 
Thesis Purpose & Hypotheses 
 The purpose of this study was to: 1) quantify the IHG stimulus in terms of the 
neurovascular responses and determine if a sex difference exists in these responses, 2) 
determine if the IHG protocol has systemic vascular effects and to determine if any 
systemic response sex differences exist, and 3) compare the response of the traditional 
IHG stimulus to a complementary IR cuff protocol within the exercised limb.  
  Due to elevations in oxidative stress, it was hypothesized that NȮ-dependent 
vasodilation would be transiently reduced in the conduit (brachial) and resistance vessels 
of the trained limb immediately following an acute bout of IHG exercise (McGowan et 
al., 2006; McGowan et al., 2007a).  Further, females were expected to experience a 
greater neurovascular response to acute IHG exercise (through greater reductions in NȮ-
dependent vasodilation and reduced resistance vessel function).  It was hypothesized that 
an acute bout of IHG exercise would produce a systemic vascular response, and that 
females would experience a greater response than males.  It was also hypothesized that 
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the IR cuff protocol would produce similar neurovascular responses to that of an acute 
bout of IHG exercise in the exercised limb.  As with IHG exercise, it was hypothesized 
that females would experience a greater vascular response.  With respect to the latter, 
sex-specific differences in the arterial BP response to IR may elucidate the observed sex 
differences in the resting arterial BP response to IHG training. 
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Chapter 2:  Sex differences in the neurovascular response to acute isometric 
handgrip exercise and a complementary ischemic-reperfusion cuff protocol 
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2.1 Introduction 
 Hypertension (HT), a condition characterized by sustained elevations of resting 
systolic (SBP) and/or diastolic blood pressure (DBP), increases the risk of developing 
cardiovascular disease (CVD) and afflicts over 4.6 million Canadians (Statistics Canada, 
2009).  Currently, CVD is a leading cause of morbidity and mortality in Canadians of 
both sexes (Statistics Canada, 2009).  Genetic and environmental factors, along with 
alterations in sex hormones with increasing age, have been implicated in the development 
of HT (Coylewright, 2008).  Although significant improvements in screening, prevention, 
and treatment have been made, HT remains a major health problem for Canadians as 
evident by the statistics presented above. Thus, primary prevention strategies targeting 
older individuals, a key population at an increased risk for HT development, are very 
important.  
 Isometric handgrip (IHG) training is a novel and simple form of isometric 
resistance exercise where participants perform multiple, timed, constant contractions 
(squeezes) on a programmed handgrip at a set percentage of their maximal voluntary 
contraction (MVC), where each contraction is separated by a timed rest period. This form 
of training, recently endorsed by the American Heart Association as a method to reduce 
BP (Brook et al., 2013), reduces both resting SBP and DBP in men and women with and 
without HT, including those currently on medication(s) to treat their HT, and those who 
regularly exercise (McGowan et al., 2006; McGowan et al., 2007a; McGowan et al., 
2007b; Millar et al., 2007, Millar et al., 2008; Peters et al., 2006; Taylor et al., 2003; 
Wiley et al., 1992; Ray & Carrasco, 2000; Badrov et al., 2013a; Badrov et al., 2013b).  
Collectively, these studies use IHG training protocols of varying frequencies (3 to 5 
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sessions per week), durations (45-second to 2-minute contractions), intensities (30 to 
50% of MVC) and intervention lengths (5- to 10-weeks). The most commonly employed 
and studied bilateral IHG protocol consists of four, two-minute contractions at 30% 
MVC, performed with alternating hands with 1-minute rest between.  The most common 
unilateral IHG protocol consists of four, two-minute contractions at 30% MVC, with 4-
minutes rest between.  Recent meta-analyses have concluded that resting arterial BP 
reductions with this form of training appear similar to, if not greater than, those observed 
with aerobic exercise training (Kelley & Kelley, 2010; Cornelissen & Fagard, 2005).  
 Older females with normal resting arterial BP appear to respond to IHG with 
greater post-training reductions in resting arterial BP than age-matched males (Millar et 
al., 2008).  Further, preliminary results from our lab suggest that this is not upheld in a 
younger cohort (Hanik et al., 2012), such that both sexes respond to IHG training with 
similar magnitudes of resting arterial BP reduction.  A small body of evidence exists to 
suggest that an acute bout of IHG (four, two-minute contractions at 30% MVC, with 2-
minutes rest between) elicits an increase in arterial BP due to vascular compression in the 
working arm increasing TPR, but no changes in HR (Araujo et al., 2011).  Further, 
elevated arterial BP returned to near rest after the first minute of post-exercise rest, 
possibly indicating the progression to PEH (Araujo et al., 2011).   PEH has been observed 
1 minute after a single 2-minute IHG contraction at 35% MVC in young healthy subjects 
(Stewart et al., 2007).  Likewise, PEH was also observed 5 minutes post-IHG bout (four 
2-minute contractions at 30% MVC with 1 minute rest intervals) in older individuals 
(Millar et al., 2009).  The arterial BP changes appear concomitant to improved cardiac 
autonomic modulation, possibly due to enhanced vagal activation after an acute bout of 
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IHG exercise (Millar et al., 2009).  However to date the studies have been underpowered 
to detect sex differences, if they do exist. As such, whether older normotensive males and 
females respond differently (i.e.: neurovascular responses such as HR, arterial BP, 
conduit & resistance vessel function, or HR variability) to an acute bout of IHG exercise, 
potentially contributing to the differences in post-training response, remains unknown.   
 The mechanisms underlying the acute and chronic arterial BP responses to IHG 
exercise remain equivocal.  Hypothesized mechanisms of post-IHG training resting 
arterial BP reductions include improvements in autonomic nervous system function (as 
assessed via direct sympathetic outflow to muscle (MSNA), or indirectly via HR 
variability), improved NȮ-dependent blood vessel (endothelial) function (McGowan et 
al., 2006; McGowan et al., 2007a; McGowan et al., 2007b; Taylor et al., 2003; Millar et 
al., 2009; Badrov et al., 2013a), and reductions in oxidative stress (Peters et al., 2006).  
The mechanisms underlying the effects of an acute bout of IHG exercise may, or may 
not, be similar.  It is conceivable that the mechanisms are multi-faceted, and may differ 
among individuals (e.g., genetics) and populations (e.g., normotensive versus unmediated 
hypertensive versus medicated hypertensive; men versus women).  Quantifying the 
neurovascular stimulus will provide valuable insight into the mechanisms of IHG-
induced arterial BP adaptations.  
 Exercise (i.e., isometric or aerobic) leads to increased O2 consumption and an 
increase in the production of ROS from oxidative metabolism (Bejma & Ji, 1999).  With 
respect to isometric exercise, increased oxidative stress has been observed following an 
acute IHG bout, and has been attributed to increased post-exercise bioavailability of Ȯ2 
via: 1) metabolite-induced production, 2) exercise-induced temperature rise and 
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mechanical-stress induced inflammation, and/or 3) ischemia-reperfusion (IR) induced 
production (Alessio et al., 2000; Holecek et al., 2004).  This transient increase in 
oxidative stress post-IHG is not unique to an isometric exercise modality, but also occurs 
after acute bouts of aerobic exercise (Bloomer et al., 2005).  Importantly, while a single 
bout of IHG exercise acutely increased ROS production and oxidative stress, this effect is 
transient, and chronic exposure to the IHG stimulus leads to adaptation and an increased 
basal antioxidant capacity (Peters et al., 2006). As with the work mentioned previously, 
samples sizes were too small to detect any sex differences in post-training improvements 
in NȮ-dependent function and/or oxidative stress.   
 The positive adaptation to acute ROS exposure has also been shown in aerobic 
exercise studies (Miyazaki et al., 2001).  With respect to aerobic exercise, transient 
increases in ROS production and consequent oxidative stress, as indicated by an 
increased ratio of oxidized glutathione-to-total whole-blood glutathione ratio 
(GSSG:TGSH), have been observed following an acute bout of aerobic exercise 
(Bloomer et al., 2005).  Participants cycled at 70% of VO2max for 30 minutes and blood 
was drawn for analysis pre, post, 1h-post, 6h-post, and 24h-post exercise.  The 
GSSG:TGSH ratio was increased immediately following exercise, but returned to 
baseline at 1h-post exercise.  The authors hypothesized that an acute increase in oxidative 
modification of TGSH occurs immediately post-exercise, increasing production of 
GSSG, but the rapid action of glutathione reductase catalyzed the conversion of GSSG to 
reduced glutathione (Bloomer et al., 2005).  It is possible that the observed oxidative 
stress in this study was due to increased Ȯ2 bioavailability.  To neutralize reactive Ȯ2 it 
can be converted to H2O2 by the enzyme SOD (Gohil et al., 1988).  H2O2 formed by this 
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reaction is then neutralized by the actions of the enzyme glutathione peroxidase, which 
converts H2O2 to H2O, but in the process produces GSSG (Gohil et al., 1988).  The 
observation of increased oxidative stress after acute aerobic exercise has been repeatedly 
shown in the literature (Alessio et al., 2000; Sastre et al., 1992; Gohil et al., 1988). 
 Although the acute effects of augmented ROS production due to aerobic exercise 
appear to be detrimental to health they may serve a very beneficial long-term purpose.  
Exposure to chronic aerobic exercise training leads to lower levels of oxidative damage 
after an intense exercise bout due to upregulation of antioxidant enzymes such as SOD, 
GPx, and glutamylcysteine synthase (Salminen & Vihko, 1983).  Likewise, increased 
SOD activity in response to aerobic training has been shown repeatedly in animal studies 
of various durations, intensities, and lengths (Higuchi et al., 1985; Powers et al., 1994; 
Leeuwenburgh et al., 1997).  If chronic aerobic exercise augments endogenous 
antioxidant production the system could neutralize greater concentrations of ROS, such 
as Ȯ2, preventing the negative effects of oxidative stress, such as reduced NȮ 
bioavailability, on resting arterial BP regulation. 
 Work by McGowan et al. (2006) indirectly supports the observation of improved 
antioxidant capacity with IHG training.  Acutely, investigators observed post-IHG bout 
reductions in NȮ-dependent vasodilation in the brachial artery of the exercised limb (an 
indirect indicator of increased oxidative stress) in an older population of medicated 
hypertensives prior to an 8-week IHG training intervention.  Although this acute response 
was unchanged with 8-weeks of IHG training, the overall resting NȮ-dependent function 
of the brachial artery was improved (McGowan et al., 2006; McGowan et al., 2007a; 
McGowan et al., 2007b).  Further, there is evidence to suggest that IHG training results in 
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improved basal NȮ-dependent resistance vessel function (McGowan et al., 2007a; 
Badrov et al., 2013a).  Increased antioxidant capacity through a repeated exposure to the 
IHG stimulus may provide a greater capacity to neutralize future increases in free radical 
production, reduce the incidence and severity of oxidative stress, improve basal NȮ-
dependent dilation supporting improved resistance vessel function, and lead to reductions 
in total peripheral resistance and resting arterial BP .  
 IR with IHG increases ROS production, as mentioned above.  It has been shown 
that exposure to ischemic conditions can increase antioxidant concentrations, which may 
lead to better protection during subsequent exposure to oxidative stress (Hoshida et al., 
1993; Powers et al., 1998).  As blood flow to the working tissues is decreased 
proportional to force during IHG exercise (Sejersted et al., 1984), and reactive hyperemia 
is increased during the recovery phase proportional to exercise intensity (Kagaya & 
Homma, 1997), it is possible that IR is an underlying mechanism of resting arterial BP 
modulation due to IHG exercise.  If the resting arterial BP reductions from IHG exercise 
could be replicated using a simple IR cuff protocol (i.e., creating IR via arterial occlusion 
using an inflatable cuff), one could quantify the stimulus and isolate IR as a potential 
causal mechanism.  Further, if there is a sex difference in the vascular response to IR it 
may provide insight into the observed sex differences in the resting arterial BP response 
to IHG exercise in older individuals (Millar et al., 2008). 
 Expansion of currently available HT prevention therapies is needed, particularly 
in older individuals at risk of developing HT.  IHG training is a novel, simple, and time-
efficient form of exercise that is effective in reducing resting arterial BP in individuals 
with and without high arterial BP, particularly in older women. The inherent sex 
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differences in response to the IHG stimulus are under-investigated.  Furthermore, the 
mechanisms responsible for the observed resting arterial BP reductions and/or existing 
sex-differences in these mechanisms, such as basal antioxidant modulation, are not well 
known. The rationale for conducting the present study is based upon these experimental 
findings. It is hoped that the results of this research will provide further support for the 
use of IHG training as a modulator of resting arterial BP, as well as shed light on possible 
associated mechanisms and sex differences.  
2.2 Purpose & Hypotheses 
 The purpose of this study was to: 1) quantify the IHG stimulus in terms of the 
neurovascular responses and determine if a sex difference exists in these responses, 2) 
determine if the IHG protocol has systemic vascular effects and to determine if any 
systemic response sex differences exist, and 3) compare the response of the traditional 
IHG stimulus to a complementary IR cuff protocol within the exercised limb.  
 Due to elevations in oxidative stress, it was hypothesized that NȮ-dependent 
vasodilation would be transiently reduced in the conduit (brachial) and resistance vessels 
of the trained limb immediately following an acute bout of IHG exercise (McGowan et 
al., 2006; McGowan et al., 2007a).  Further, females were expected to experience a 
greater neurovascular response to acute IHG exercise (through greater reductions in NȮ-
dependent vasodilation and reduced resistance vessel function).  It was hypothesized that 
an acute bout of IHG exercise would produce a systemic vascular response, and that 
females would experience a greater response than males.  It was also hypothesized that 
the IR cuff protocol would produce similar neurovascular responses to that of an acute 
bout of IHG exercise in the exercised limb.  As with IHG exercise, it was hypothesized 
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that females would experience a greater vascular response.  With respect to the latter, 
sex-specific differences in the arterial BP response to IR may elucidate the observed sex 
differences in the resting arterial BP response to IHG training.  
 
2.3 Methods 
 Study Participants 
 A total of eight non-smoking, recreationally active (2-3x / week), healthy men 
(n=1); 63 years, and women (n=7); 65 ± 4 years, with normal arterial BP (man: 103 ± 13 
SBP/68 ± 7 DBP; women: 100 ± 10 SBP/60 ± 5 DBP) were recruited from Essex county 
and enrolled in the protocol.  Exclusion criteria included any arterial BP or vascular 
altering medications, recent hospitalization (<3 months), use of hormone replacement 
therapy, diabetes (by history, use of oral hypoglycemic agents or a fasting blood glucose 
value >7.0 mmol/L), autonomic neuropathy, frequent premature ventricular heart beats or 
a paced heart rhythm at rest, CVD and/or heart failure.  The University of Windsor 
Research Ethics Board approved the study described herein (REB # 12-207). 
 Sample size was calculated with consideration of the neurovascular responses 
following IHG exercise (Millar et al., 2009; McGowan et al, 2006; McGowan et al, 
2007a).  With an assigned alpha of 0.05, a beta of 0.2 and an effect size of 0.4, sample 
sizes ranging from 6 to 16 were estimated. 
 Study Design 
 After inquiring about the study, potential participants who believed they met the 
inclusion criteria met with investigators at the Physical Activity and Cardiovascular 
M.H.K. Thesis – J. Seifarth University of Windsor – Applied Human Performance 
	   70	  
Research lab (PACR; HK 240, Department of Kinesiology, University of Windsor, ON, 
Canada) for an informational meeting and, if interested, to sign an informed letter of 
consent (Appendix A), a letter of information (Appendix B), followed by the 
administration of a medical questionnaire (Appendix C) to determine eligibility.  Upon 
review of the medical questionnaire and the initial establishment of initial eligibility, 
participants had their resting arterial BP measured.  Resting arterial BP was measured 
following 10-minutes of seated rest using the Dinamap brachial artery oscillometric 
device (Appendix D; Dinamap Carescape v100, Critikon, Tampa, Florida, USA).  
Specifically, arterial BP measurements involved the placement of a cuff around the right 
arm (upper portion), which was inflated to a pressure greater than systolic BP to occlude 
the brachial artery.  Arterial BP was measured 4 times, with a 2-minute rest period 
between measures, and the last 3 values were then averaged (Stiller-Moldovan et al., 
2012; Badrov et al., 2013a; Badrov et al., 2013b).  
 If resting arterial BP was within the eligible range (< 140/90 mmHg) individuals 
who were still interested were given a physical activity readiness medical examination 
(PAR-MedX) questionnaire if over the age of 70 years (Appendix E), or a PAR-Q if 
under the age of 70 years (Appendix F) and a letter of information for their primary 
healthcare provider (Appendix G), both of which were signed by their health care 
provider (HCP) and returned to the study investigators prior to the scheduling of the 
familiarization session. 
 Upon completion of all forms, individuals returned to the PACR lab for a 
familiarization session.  First, participants had their resting arterial BP measured a second 
time in the same manner as described above. If average resting arterial BP values from 
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Visit 1 and Visit 2 were < 140/90 mmHg participants were deemed eligible to participate, 
and continued with the habituation session and the investigation.  Participants then 
practiced all portions of the investigation including the IHG exercise protocol.  Any 
further questions or concerns related to the study were answered at this time.  This 
session also functioned to reduce participant anxiety as well as reduce possible white coat 
effects during subsequent BP readings (Verdecchia et al., 2001).  Following the 
completion of the familiarization session, testing was then conducted on three separate 
days to evaluate neurovascular function (Figure 1; pre- to post-IHG exercise in the 
exercised and non-exercised arm, and pre- to post-IR cuff protocol in the cuffed arm). 
 
 Figure 1. Vascular testing days 
 Testing Protocol 
 Testing days were conducted in random order, and were separated by at least 24 
hours. To minimize the influence of external factors on the cardiovascular measurements, 
participants were asked to refrain from the consumption of alcohol or the participation in 
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vigorous exercise for 24 hours prior to each testing session, to avoid caffeine 
consumption for 12 hours prior, and following a 4 hour fast.  All testing was conducted in 
a quiet, temperature-controlled room at the same time of day according to standardized 
published procedures (Stiller-Moldovan et al., 2012). Participants were asked to void 
their bladder prior to all testing sessions to minimize the effects of bladder distension on 
resting arterial BP (Fagius & Karhuvaara, 1989). 
TESTING DAY 1: Assessment of neurovascular function (indirect assessment of 
oxidative stress) prior to and following an acute IHG bout in the exercised arm (Time: 2.5 
hours) 
 After 10 minutes of seated rest, arterial BP was be measured 4 times in the right 
arm with a 2-minute rest period between measures, and the last 3 values were then 
averaged, as described above.  Following arterial BP acquisition, participants remained in 
a seated position with their non-dominant arm adjusted to an angle of ~90° from their 
upper arm, while their arm was rested on a table located directly in front of the 
participant. A rapid inflating BP cuff was also placed around the non-dominant forearm 
(2-4 cm distal to the antecubital fosse).  A 3-lead ECG was attached to record continuous 
HR data throughout the protocol (Appendix H; Powerlab ML 870/P, AD Instruments, 
Colorado Springs, Colorado, USA). 
 Neurovascular Measure #1: Brachial artery NȮ-dependent vasodilation was 
assessed using a flow-mediated dilation (FMD), a gold standard validated technique, in 
accordance with international guidelines (Harris et al., 2010).  A linear array vascular 
probe (8L-RS; 13MHz), attached to a high-resolution Doppler ultrasound machine 
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(Appendix I; Vividi, GE Healthcare, Pittsburgh, PA, USA) was used to image the 
brachial artery in the distal third of the upper arm. Ultrasound gel was applied to the area 
of interest and ultrasound parameters were set to optimize the clarity of the brachial 
artery image. The placement of the probe and anatomical landmarks were recorded for 
future imaging sessions to ensure identical placement of the probe during repeat testing.  
All recording was performed at an insonation angle of 60 degrees.  Recording sample 
volume spanned the entire width of the artery, but was clear of the vessel walls.  A rapid 
inflation/deflation cuff was inflated to 200mmHg and held at a constant pressure for 5 
minutes to occlude blood flow, after which time the cuff was released and blood flow 
restored to the lower arm.  In brief, brachial artery diameters (B Mode) and blood 
velocity (PW mode) were recorded continuously for 1 minute prior to cuff inflation and 
for 3 minutes following cuff release. 
 Participants then completed a single bout of IHG, comprising 4, 2-minute 
isometric contractions at 30% MVC (determined at the onset of exercise via electronic 
linear load cells contained within each IHG device) using the same hand with a 4-minute 
rest interval between on a programmed handgrip dynamometer (Appendix J; ZonaPLUS, 
Zona HEALTH, Boise, Idaho, USA).  Upon completion of this bout, measures of FMD 
were repeated. 
 Participants then underwent 30 minutes of supine rest before measures of 
resistance vessel function were taken. 
 Neurovascular Measure #2: Venous strain-gauge plethysmography (Appendix 
K; Hokanson EC6 Strain Gauge and Photo Plethysmograph, D.E. Hokanson, Inc., 
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Bellevue, Washington, USA) with reactive hyperemia was used to assess resistance 
vessel function (Badrov et al., 2013a).  The non-dominant upper-arm was elevated above 
heart level and fitted with an inflatable cuff (Appendix L; Hokanson Cuff, D.E. 
Hokanson, Inc., Bellevue, Washington, USA).  The largest part of the forearm was then 
fitted with a strain gauge (Hokanson EC6 Strain Gauge and Photo Plethysmograph, D.E. 
Hokanson, Inc., Bellevue, Washington, USA).  The non-dominant wrist was then fitted 
with a small cuff, which was inflated 60 seconds prior to resting blood flow measurement 
to a pressure above SBP (200mmHg).  Venous blood flow emptying was achieved by 
inflating the upper arm cuff to 60mmHg (a pressure below DBP) for intervals of 10 
seconds, followed by 5 seconds of deflation.  Three resting blood flow measurements 
were performed over 1 minute to calculate mean resting blood flow.  Following resting 
blood flow measurements, forearm ischemia (occlusion of arterial blood flow to the 
forearm) was achieved by inflating the cuff on the upper arm to 200mmHg.  After 5-
minutes, the upper arm cuff was released and forearm blood flow was measured every 10 
seconds for a total of 60 seconds.  Following these measurements, the strain gauge and 
wrist cuff was removed from the participant, and his/her arm was lowered to his/her side. 
 Participants then completed a single bout of IHG as described previously in 
Neurovascular Measure 1.  Upon completion of this bout, measures of resistance vessel 
function were repeated.   
 Neurovascular Measures #1 and #2 occurred in random order on each testing day 
to minimize any potential order effects.  
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TESTING DAY 2: Assessment of neurovascular function (indirect assessment of 
oxidative stress) prior to and following an acute IHG bout in the non-exercised arm 
(Time: 2.5 hours) 
 Testing Day 2 mirrored Testing Day 1 with the following exception: 
neurovascular measures were performed in the non-exercised arm. 
TESTING DAY 3: Assessment of neurovascular function (indirect assessment of 
oxidative stress) prior to and following an acute IR cuff protocol (Time: 2.5 hours) 
 Testing Day 3 procedures were identical to Testing Day 1 procedures with the 
exception of the acute IHG bout. The acute IHG bout was replaced by a single bout of the 
ischemic-reperfusion cuff protocol that mimics the IHG protocol. Participants had an 
inflatable cuff (Appendix L; Hokanson Cuff, D.E. Hokanson, Inc., Bellevue, Washington, 
USA) positioned on their non-dominant forearm 3cm distal to the olecranon process.  A 
rapid inflation/deflation cuff was inflated to 200mmHg and held at a constant pressure for 
2 minutes to occlude blood flow, after which time the cuff was released, and the 
participants then had a 4-minute rest period. This sequence was repeated 4 times in 
succession to complete the bout, mimicking the IHG exercise protocol.  
 Data Analysis 
 Brachial artery blood flow velocity.  Mean blood flow velocity signals post-
occlusion were recorded from the ultrasound (Vividi, GE Healthcare, Pittsburgh, PA, 
USA) using customized software (Stoik Capturer, Moscow, Russia) directly onto a PC 
(Dell Optiplex 980, Toronto, Ontario, Canada) as Audio Video Interleave (AVI) files.  
AVI files were converted to Waveform Audio (WAV) files for processing.  WAV files 
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were then processed using customized software to determine mean blood flow velocity 
for each QRS interval (Hemodynamic IQ, Windsor, ON, Canada).  Mean blood flow 
velocity was then analyzed using rolling 3-frame average bins (Thijssen et al., 2011), 
within which the peak bin value was ascertained. Each frame corresponded to a single 
QRS interval.  Resting velocities were recorded for 60-seconds pre-occlusion for later 
manual analysis (Vividi, GE Healthcare, Pittsburgh, PA, USA).  The average of a 20-
frame segment was used to determine mean resting blood velocity.  The coefficient of 
variation for blood velocity using our customized program versus traditional manual 
Doppler ultrasound measurements of mean blood velocity in our laboratory is 4.4%. 
 Brachial artery diameter. Vessel diameter was determined using automated edge-
detection software (Artery Measurement System (AMS) v2.0, Gothenburg, Sweden).  A 
Digital Imaging and Communications in Medicine (DICOM) image was saved at end-
diastole for every QRS interval for the entirety of the resting (60 sec) and post-occlusion 
(180 sec) recordings and merged into two (resting, post-occlusion) stacked DICOM series 
using DICOM editing software (Sante DICOM Editor version 9.10.9200.16721, 
Santesoft, Athens, Greece).  The stacked DICOM files were then analyzed using AMS 
software (Artery Measurement System (AMS) v2.0, Gothenburg, Sweden).  This 
program allows a user to identify a region of interest along the portion of the vessel 
where the near and far walls are clearest.  The program collects one diameter measure for 
each pixel column within the region of interest and provides a mean diameter for the 
entire frame (approximately 100 measurements).  All brachial artery diameters were 
measured from leading edge to leading edge. 
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 Figure 2. Assessment of BA diameter using AMS 
 Resting diameter measures were determined by averaging the 20-frame segment 
of diameters corresponding to the segment used to determine resting blood velocity 
measures.  Brachial artery diameter measures post-release were analyzed using rolling 3-
frame average bins.  This allowed for diameter and velocity measurements to be frame-
aligned at all time points both at rest and post-release (Thijssen et al., 2011). 
Both inter- and intra-observer reproducibility were conducted on resting BA 
diameter measures as this had yet to be done in our laboratory.  The inter-observer 
coefficient of variation was calculated using the formula: CV = SD of resting BA 
diameter from Investigator 1 & 2 / mean resting BA diameter from investigator 1 & 2 * 
100, using measures taken on the CUFF testing day (pre-cuff). Inter-observer method 
error was calculated using the formula: ME = SD of the difference between investigator 1 
& 2 / Grand Mean * 100, using measures on the CUFF testing day.  The inter-observer 
correlation coefficient was calculated by correlating the resting BA diameter measures of 
investigator 1 with those from investigator 2.  Intra-observer reproducibility was 
determined using pre-cuff resting BA diameter values from the CUFF testing day 
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compared to those of the EIHG testing day.  The coefficient of variation was 2.01%, the 
method error was 3.16%, and the correlation coefficient was 0.97 for resting BA diameter 
inter-observer reproducibility (Appendix Q).  For resting BA diameter intra-observer 
reproducibility, the coefficient of variation was 3.10%, the method error was 5.71%, and 
the correlation coefficient was 0.97 (Appendix Q). 
Resting and peak blood flows. Resting blood flow was determined using the mean 
circumference of the artery at rest calculated using mean diameter values (cm) and 
resting mean blood velocity values (cm/s).  Resting diameter and velocity values were 
determined using corresponding 20-frame bin segment means (Thijssen et al., 2011).  
The formula used to calculate resting blood velocity was PI * ((mean resting diameter / 2) 
^ 2) * mean resting velocity * 60 and the final value was expressed as milliliters per 
minute (ml/min).  Peak blood flow was determined using the peak circumference of the 
artery calculated using peak diameter values (cm) and peak mean blood velocity values 
(cm/s).  Peak diameter and mean blood velocity values were determined using 
corresponding 3-frame bin segment means (Thijssen et al., 2011).  The formula used to 
calculate peak blood velocity was PI * ((mean resting diameter / 2) ^ 2) * mean peak 
blood velocity * 60 and the final value was expressed as milliliters per minute (ml/min). 
Flow mediated dilation. Absolute flow mediated dilation, expressed in 
millimeters, was calculated using the formula: FMD (mm) = Peak Diameter - Baseline 
Diameter, where peak diameter was the highest 3-frame bin post-occlusion and baseline 
diameter was the mean of 20 frames recorded pre-occlusion on the ultrasound (Vividi, 
GE Healthcare, Pittsburgh, PA, USA).  Relative flow mediated dilation was calculated 
using the formula: FMD (%) = [Peak Diameter - Baseline Diameter] / Baseline 
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Diameter*100, and reported as percentage change (Corretti et al., 2002).  FMD was also 
normalized using shear rate area under the curve and reported as such.  The formula used 
for normalization was FMD (%) / AUC(s^-1)*1000 (Pyke & Tschakovsky, 2007).  It is 
important to note that normalized FMD to AUC should only be considered if there is at 
least a consistent, moderate correlation among measures across all research settings 
(Thijssen et al., 2011).  A consistent, moderate correlation was not found within this 
study. 
 Shear rate area under the curve.  Shear rate area under the curve (AUC) was 
calculated using velocity and diameter values derived as outlined above.  Shear rate for 
each rolling 3-frame bin segment was calculated using the formula: 8*mean blood 
velocity / diameter (Harris et al., 2010).  Shear rates were calculated from cuff release 
until peak diameter, signifying peak dilation.  Shear rates were graphed over the time 
interval from cuff release to peak dilation, and AUC was calculated using a macro within 
the statistical software (SigmaPlot 11.0, Systat Software Inc, San Jose, California). 
 Resistance vessel function.  Resistance vessel function was determined using 
venous strain-gauge plethysmography.  All data were recorded using PowerLab hardware 
(ML870 PowerLab 8/30) onto LabChart 7 Pro v7.3.7 (ADInstruments, Colorado Springs, 
CO) on a PC (Dell Optiplex 980, Toronto, Ontario, Canada).  The slope of the flow over 
the first three cardiac cycles for each baseline blood flow curve was determined for each 
of three measures, and these slopes were then averaged, to determine mean baseline 
blood flow.  After 5-minutes of complete occlusion (200 mmHg), one measure of peak 
blood flow was recorded.  The slope of the first 3 cardiac cycles of the first blood flow 
curve was recorded as the peak blood flow post-occlusion and used for analysis.  
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Resistance vessel function, expressed as percentage change, was then calculated using the 
formula: RVF = [Peak Flow - mean Baseline Flow] / mean Baseline Flow * 100.  The 
intra-observer reproducibility of resistance vessel endothelial function in our laboratory 
is: 6.6 % (coefficient of variation), 2.2 % (method error), and 0.92 (correlation 
coefficient).  The inter-observer reproducibility of resistance vessel endothelial function 
in our laboratory is: 4.3 % (coefficient of variation), 10.4 % (method error), and 0.93 
(correlation coefficient) (Badrov et al., 2013a). 
See Appendix O for raw data. 
 Statistical Analysis 
 Baseline data was analyzed using one-way analysis of variance (ANOVA) to 
determine if there were baseline differences between testing days.  Outcome data were 
analyzed using two-way (Time X Exercise) ANOVA with repeated measures.  Tukey 
post hoc procedures were used to evaluate specific differences between means where 
applicable (SigmaPlot, v.11.0). An alpha level of < 0.05 was considered statistically 
significant. Data are presented as mean ± standard deviation (SD), unless otherwise 
specified.  See Appendix P for detailed statistical analysis. 
2.4 Results 
 Participant baseline characteristics are displayed in Table 1.  During active 
recruitment over a period of 6 months, 10 males and 26 females expressed interest in 
participating in the study.  Of those expressing interest, 6 males and 17 females scheduled 
an initial visit.  Due to inclusion and/or exclusion criteria (medication use, activity levels, 
health status), 4 males and 6 females were deemed ineligible during the initial visit, and 
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one further male was deemed ineligible during the second visit.  Further, 3 females 
voluntarily withdrew, and an additional female and 2 males did not attend their scheduled 
visits.  Given a final participant total of 7 females, but only a single male, the male data 
was excluded from further statistical analyses.  Primary barriers to participation included 
medication use, the opportunity cost of time away from work, and the duration of testing 
days.  There were no reported changes in exercise, diet, and/or medication throughout the 
investigation among all participants.  Further, there were no statistically significant 
differences in baseline SBP, DBP, MAP, HR, pre-exercise resting blood flow, pre-
exercise peak blood flow, or brachial artery diameters on any of the testing days (all p > 
0.05).  However, baseline FMD and RVF were not strongly correlated between the CUFF 
and EIHG testing days indicating day-to-day variability within these measures. 
Table 1. Participant characteristics 
  Male Female 
N 1 7 
Age (years) 63 65 ± 5 
Height (cm) 180 161 ± 6 
Weight (kg) 74 68 ± 8 
BMI 23 26 ± 4 
Resting SBP (mmHg) 103 ± 13 100 ± 10 
Resting DBP (mmHg) 68 ± 7 60 ± 5 
Resting MAP (mmHg) 80 ± 8 74 ± 5 
Resting HR (BPM) 60 ± 5 69 ± 5 
SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial blood 
pressure; HR, heart rate. Values are mean ± SD.  All p > 0.05. 
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Resting Mean Blood Flow and Peak Mean Blood Flow 
 There were no significant differences in resting mean blood flow between 
exercise days either pre-, or post-, exercise intervention (Table 2).  Likewise, there were 
no significant differences in peak mean blood flow between exercise days either pre, or 
post, exercise intervention (Table 2).  Further, there were no significant differences in 
baseline of peak BA diameter measurements between testing days. 
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Table 2. Vascular reactivity following exercise intervention (n = 7) 
Testing Day 
 CUFF EIHG NEIHG 
Resting MBF (cm/s) Pre 32.52 ± 20.52 34.10 ± 18.41 33.73 ± 15.11 
 
Post 31.31 ± 26.46 36.51 ± 12.04 25.19 ± 7.06 
     
Resting BA Diameter (mm) Pre 2.89 ± 0.34 2.94 ± 0.48 3.10 ± 0.31 
 
Post 2.92 ± 0.40 2.93 ± 0.31 3.05 ± 0.38 
 
    
Resting SR (s-1) Pre 
22.64 ± 12.46 21.29 ± 4.11 18.86 ± 6.67 
Post 
22.38 ± 18.67 26.75 ± 15.26 15.31 ± 4.07 
     
Peak MBF (cm/s) Pre 419.26 ± 168.53 464.05 ± 206.80 422.73 ± 100.02 
 
Post 380.47 ± 87.60 446.45 ± 135.66 470.94 ± 174.39 
     
Peak BA Diameter (mm) Pre 3.20 ± 0.40 3.47 ± 0.75 3.40 ± 0.31 
 
Post 3.12 ± 0.31 3.32 ± 0.55 3.28 ± 0.29 
 
    
Peak SR (s-1) 
Pre 239.34 ± 80.10 219.87 ± 52.35 207.62 ± 38.82 
Post 229.42 ± 40.67 234.78 ± 45.82 238.23 ± 55.49 
CUFF, ischemic-reperfusion cuff testing day; EIHG, isometric handgrip testing day with 
vascular measures on the exercised arm; NEIHG, isometric handgrip testing day with 
vascular measures on the non-exercised arm; Pre, pre exercise/cuff intervention; Post, 
post exercise/cuff intervention; MBF, mean blood flow; BA, brachial artery; BF, blood 
flow; SR, shear rate. Values are mean ± SD.	  All p > 0.05. 
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Flow Mediated Dilation 
 There were no significant differences noted in relative FMD post-exercise in any 
of the three exercise bouts (Table 3).  See Appendix R for FMD scatter plots by testing 
day.  Normalization of relative FMD to shear rate AUC also showed no significant 
differences post-exercise for any of the three exercise bouts (Table 3).  Additionally, 
there were no significant differences in shear rate AUC post-bout on any of the testing 
days. 
Table 3. Flow mediated dilation following exercise interventions (n = 7) 
Testing Day 
 CUFF EIHG NEIHG 
Relative FMD (% change) Pre 10.86 ± 6.94 13.76 ± 11.74 8.41 ± 7.01 
Post 8.89 ± 8.62 13.32 ± 13.4 7.74 ± 5.12 
     
SR AUC (s^-1) Pre 4316.96 ± 
2759.36 
4177.18 ± 2408.96 2494.96 ± 
3027.78 
Post 3392.90 ± 
2409.29 
4416.80 ± 2359.98 3286.47 ± 
1682.01 
     
Normalized FMD 
(FMD:AUC) 
Pre 3.25 ± 2.08 5.14 ± 4.65 7.08 ± 7.95 
Post 3.57 ± 3.05 4.01 ± 3.85 2.61 ± 2.18 
CUFF, ischemic-reperfusion cuff testing day; EIHG, isometric handgrip testing day with 
vascular measures on the exercised arm; NEIHG, isometric handgrip testing day with 
vascular measures on the non-exercised arm; Pre, pre exercise/cuff intervention; Post, 
post exercise/cuff intervention; FMD, flow-mediated dilation; SR, shear rate; AUC, area 
under curve. Values are mean ± SD.  All p > 0.05. 
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Resistance Vessel Function 
 There were no significant differences noted in resistance vessel function post-
exercise in each of the three exercise interventions (Table 4).  See Appendix R for RVF 
scatter plots by testing day. 
Table 4. Resistance vessel function following exercise interventions (n = 6*) 
Testing Day 
 
CUFF EIHG NEIHG 
RVF (% change) Pre 1107.16 ± 
742.27 
447.30 ± 283.93 505.35 ± 326.12 
Post 753.44 ± 434.06 333.49 ± 228.80 859.0 ± 290.93 
CUFF, ischemic-reperfusion cuff testing day; EIHG, isometric handgrip testing day with 
vascular measures on the exercised arm; NEIHG, isometric handgrip testing day with 
vascular measures on the non-exercised arm; Pre, pre exercise/cuff intervention; Post, 
post exercise/cuff intervention; RVF, resistance vessel function. Values are mean ± SD.  
All p > 0.05. * One participant was removed from statistical analysis as data was missing 
due to equipment malfunction. 
2.5 Discussion 
  HT is a major modifiable risk factor for the development of CVD (WHO, 2013).  
Recently, the World Health Organization has identified HT as a global epidemic (WHO, 
2013).  IHG training is an effective means of lowering resting arterial BP in numerous 
populations (McGowan et al., 2006; McGowan et al., 2007a; McGowan et al., 2007b; 
Taylor et al., 2003; Millar et al., 2009; Badrov et al., 2013a).  Interestingly, older females 
with normal resting arterial BP appear to respond to IHG with greater post-training 
reductions in resting arterial BP than age-matched males (Millar et al., 2008).  The 
mechanism(s) underlying the reduction in resting arterial BP due to IHG training are 
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currently unknown.  It has been proposed that transient exposure to oxidative stress, due 
to IR induced by the IHG contraction, may promote an adaptive response and an 
increased basal antioxidant capacity (Peters et al., 2006).  This increased basal 
antioxidant capacity more readily neutralizes oxidative free radicals, increasing the 
bioavailability of NȮ, improving endothelial function and potentially lowering resting 
arterial BP.  Due to poor recruitment of male participants, this study was unable to 
address possible sex differences described in the initial hypotheses.  However, this is the 
first study conducted to explore IR as an underlying mechanism modulating resting 
arterial BP in response to IHG exercise.  Further, this is the first study to compare acute 
IHG exercise to IR induced by a simple cuff.   
2.5.1 Effects of an Acute Bout of IHG Exercise on Vascular Reactivity in the 
Exercised Arm 
 No significant differences were found in FMD, normalized FMD, or resistance 
vessel function (RVF), indicating that an acute bout of IHG did not significantly alter 
vascular reactivity in the exercised arm.  However, there were consistent mean trends in 
the data.  Mean vascular reactivity in the exercised arm was suppressed post-IHG 
exercise when assessed via FMD (13.76 ± 11.74% to 13.32 ± 13.40%), normalized FMD 
(5.14 ± 4.65 to 4.01 ± 3.85), and RVF (447.30 ± 283.93% to 333.49 ± 228.80%).  The 
acute IHG exercise protocol used in this investigation was unilateral in the non-dominant 
arm, with 4-minutes rest between contractions.  In contrast, the protocol used by Peters 
and colleagues (2006) was a bi-lateral protocol with 1-minute rest between contractions.  
As such, the added 3-minutes of rest after the final contraction before post-IHG testing 
may have functioned as a washout period reducing the possibility of noting any changes 
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in vascular reactivity. Alternatively, it is possible that the limited number of participants 
(n=7), and their degree of inter-individual variation, did not allow for adequate power to 
detect significant changes in vascular reactivity following an acute IHG bout.  
 The potential also exists that the acute bout of IHG exercise used in this study did 
not provide a stimulus strong enough to elicit an acute state of oxidative stress.  If the 
basal antioxidant capacity of the participants was not exceeded it is conceivable that NȮ 
bioavailability may not have been decreased enough to elicit a significant change in acute 
vascular reactivity.  However, if this were indeed true, it would diminish the possibility 
that modulations in basal antioxidant capacity due to repeated bouts of acute IHG 
exercise is a mechanism underlying the resting arterial BP response to IHG training.  
Nonetheless, further investigation with increased power is necessary.  
2.5.2 Effects of an Acute Bout of IHG Exercise on Vascular Reactivity in the Non-
Exercised Arm 
 Similar to that observed after an acute IHG bout in the exercised arm, no 
significant differences were found in FMD normalized FMD, or RVF in the non-
exercised arm.  However, while FMD (8.41 ± 7.01% to 7.74 ± 5.12%), and normalized 
FMD (7.08 ± 7.95 to 2.61 ± 2.18), both trended down in a similar direction to that of the 
exercised arm, RVF (505.35 ± 326.12% to 859.00 ± 290.93%) did not follow this trend  
Peak MBF, an indirect index of RVF, also increased post IHG bout in the non-
exercised arm mirroring the RVF measure.  This provides further support for the 
observation that an acute IHG exercise bout did not decrease vascular reactivity in the 
RVF of the non-exercised arm.  As described previously, the acute IHG exercise protocol 
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used in this investigation was unilateral in the non-dominant arm, with 4-minutes rest 
between contractions.  The added 3-minutes of rest between the final contraction and 
vascular reactivity testing may function as a washout period, reducing the possibility of 
noting any changes.   
 Given that FMD is an indicator of vascular reactivity in the larger conduit arteries 
(Corretti et al., 2002), and RVF is an indicator of vascular reactivity in the smaller 
downstream vessels (Higashi & Yoshizumi, 2003), it is possible that the stimulus strength 
was lower in the non-exercised arm and thus did not effect the downstream resistance 
vessels as potently.  If an acute bout of IHG exercise does indeed elicit localized IR and, 
in turn, localized oxidative stress, it is possible that these excess free radicals are 
neutralized before reaching the distal resistance vessel of the contralateral arm.  However, 
this may indicate that an acute bout of IHG exercise does not elicit a systemic effect, at 
least not at the level of the resistance vessel, putting into question their role in the known 
resting arterial BP response to IHG exercise.  
 Furthermore, the role of arm dominance cannot be discounted when comparing 
the response to an acute IHG bout.  As all exercise was conducted in the non-dominant 
arm, vascular reactivity on this testing day was measured in the dominant arm.  It is 
possible that, due to favoured use over the lifespan, the dominant arm is relatively more 
trained than the non-dominant arm.  As such, the stimulus provided by the acute IHG 
bout in the non-dominant arm may have not been strong enough to elicit any changes in 
vascular reactivity in the dominant arm.  As touched on previously, the variability 
between the small number of participants (n=7) makes it difficult to draw clear 
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conclusions.  Nonetheless, the difference in trends of vascular reactivity in the exercise 
and non-exercised arms does provide interesting theoretical implications. 
2.5.3 Effects of an Acute Bout of Ischemic-Reperfusion on Vascular Reactivity in the 
Reperfused Arm 
 In response to a bout of IR mimicking the timing and duration of the IHG 
protocol there were no significant differences observed in vascular reactivity measured in 
the arm of reperfusion.  Although not statistically significant, both FMD (10.86 ± 6.94 to 
8.89 ± 8.62) and RVF (1107.16 ± 742.27% to 753.44 ± 434.06%) decreased post-IR as 
observed in the exercised arm after a bout of IHG.  Interestingly, once FMD was 
normalized to shear rate area under the curve this trend was reversed (3.25 ± 2.08 to 3.57 
± 3.05).  However, as previously stated, normalization of FMD to AUC should only be 
considered when there is at least a correlation across all research settings (Thijssen et al., 
2011).  Given that a consistent, moderate correlation did not exist between these 
measures in this study relative FMD would be a more applicable index of vascular 
reactivity (See Appendix P).  
 The IR protocol applied in this investigation used an inflation pressure of 200 
mmHg, a pressure significantly above SBP, to ensure full occlusion of the lower arm.  As 
such, this stimulus may be stronger than that of an acute IHG bout as IHG does not elicit   
ischemia progressively until 30% MVC and above (Sadamoto et al., 1983; Sakakibara & 
Honda, 1990).  It is therefore conceivable that oxidative stress would be increased to a 
greater degree via the cuff than that of the IHG, leading to greater reductions in vascular 
reactivity after IR induced by a cuff.  However, a lack of significance does not allow for 
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meaningful comparison.  Although the direction of mean changes between the cuff and 
the acute IHG bout in the exercised arm are similar, a lack of statistical significance, 
likely due to a lack of power, does not allow for adequate comparison.   
 The position of the IR cuff used to mimic the acute IHG bout in this study was 
located on the forearm.  The rationale behind this placement was that muscular 
contraction during a bout of IHG is primarily in the forearm, however contributions from 
the muscles of the upper arm cannot be ruled out.  If the IR cuff was placed above the 
elbow, eliciting occlusion and reperfusion of a greater tissue volume as well as part of the 
brachial artery, it is likely that the stimulus strength would be higher, which may produce 
differing results.  An interesting direction of future research would be the comparison of 
various IR cuff pressures and positions to an IHG exercise bout to determine relative 
equivalencies.  This would allow for more direct IR stimulus comparisons. 
2.6 Perspectives 
 A number of interesting and important concepts were explored within this project, 
including the acute effects of a bout of IHG exercise, the role of IR as a potential 
mechanism underlying resting arterial BP changes in response to IHG exercise, and the 
systemic effects of an acute bout of IHG exercise.  Further, the difficulties in studying 
this specific population were identified for future investigations.  Participant recruitment 
was of particular difficulty predominantly due to the medical status of most individuals 
within this population as well as the time commitment necessary to complete the study.  
Post hoc sample size analysis determined a sample size range of 5 to 217, depending on 
the variable, to reach statistical significance.  Future studies should attempt to quantify IR 
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stimuli relative to IHG contraction strengths to determine relative equivalencies, compare 
an equivalent IR stimuli to the most common IHG exercise protocols in the training 
literature, including the most common bilateral protocol which employs minimal rest 
between contractions, investigate potential differences in vascular reactivity after an 
acute bout of IHG in the exercised and non-exercised arms to determine systemic effects, 
and investigate IR training to determine if resting arterial BP would decrease similar to 
that observed after IHG training.  As the limited male participant recruitment of this 
study did not allow for a sex-based comparison, the response to an acute bout of IHG 
between sexes should also be investigated. 
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Appendix A: Informed Consent  
 
CONSENT TO PARTICIPATE IN RESEARCH 
Title of Study: Gender differences in the neurovascular response to 
acute isometric handgrip exercise and a complimentary ischemic-
reperfusion cuff protocol 
You are asked to participate in a research study conducted by Josh Seifarth, 
BHk, & Dr. Cheri McGowan, PhD, from the Department of Kinesiology at 
the University of Windsor. 
If you have any questions or concerns about the research, please feel to 
contact Josh Seifarth via telephone (519-253-3000 ext. 4979). 
PURPOSE OF THE STUDY 
 
Hypertension increases the risk of cardiovascular disease. Isometric 
handgrip exercise (constant squeeze) training is a type of exercise training 
that lowers blood pressure (BP) in people with and without high BP. The 
goal of this study is to see if men and women respond differently (i.e., blood 
pressure, heart rate, blood vessels) to a single bout of handgrip exercise. We 
will also see if inflating a cuff around your lower arm will have the same 
results as a single bout of handgrip exercise. 
 
Familiarization Session (30 minutes):  
In the familiarization session, you will be introduced to all the techniques 
that will be used in this study. To minimize anything that may influence 
results, we will ask you to refrain from the consumption of alcohol and 
participation in vigorous exercise for 24 hours prior to each testing session, 
and to avoid caffeine consumption for 12 hours prior. Further, we ask that 
you refrain from eating for 4 hours prior to all testing sessions. All testing 
will be conducted in a quiet, temperature-controlled room at the same time 
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of day. You will be asked to void their bladder prior to all testing sessions to 
minimize the effects of a full bladder on resting BP. 
The following testing days will be conducted in random order, and the 
testing measures within each day will also be in random order. 
Testing Day 1 (approximately 3 hours):   
First, your resting blood pressure will be measured in your upper arm after 
10 minutes of seated rest. Your blood pressure will be measured 4 times, 
with 2-minutes of rest between measures. This will repeated again at least 
24-hours after Testing Day 1.  
Next, while remaining seated, a blood pressure cuff will be placed on your 
non-dominant forearm. A technique called flow-mediated dilation will be 
used on your upper arm to measure the size of your artery and the speed of 
blood flowing through it.  To do this a probe with ultrasound gel will be 
placed on your upper arm. The cuff on your forearm will be inflated to 
~200mmHg for 5 minutes and then released.  Next, you will engage in 4 
bouts of handgrip exercise in your non-dominant arm comprising 2-minute 
squeezes with 4-minute breaks between each.  Following the exercise, 
measures of artery size and blood flow will be repeated.  You will then lie 
on your back for 30 minutes of rest.  
After 30 minutes of rest, blood vessel function will be measured using a 
technique called venous strain-gauge plethysmography.  In this procedure, 
your non-dominant arm will be elevated above heart level and a rubber 
strain gauge (similar to an elastic) will be placed around the largest part of 
your forearm. A cuff will be placed on your wrist and will be inflated to a 
pressure above systolic BP (generally close to 200mmHg).  The cuff on your 
upper arm will be inflated for 10 seconds and then released for 5 seconds, 
and this will continue for 1 minute.  Next, the upper arm cuff will be inflated 
to 200mmHg for 5 minutes and then released.  Forearm blood flow will be 
measured every 10 seconds for 1 minute after the cuff is released.  You will 
then engage in 4 bouts of handgrip exercise in your non-dominant arm 
comprising 2-minute squeezes with 4-minute breaks between each.  
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Following the exercise, the blood vessel function technique will be repeated 
as described above.  
Testing Day 2 (approximately 3 hours):  
Testing Day 2 will mirror Testing Day 1 with the following exception: 
testing measures will be performed in the non-exercised limb.  You will 
exercise using the same arm as Testing Day 1 (non-dominant arm), but we 
will measure all of our variables in your non-exercising arm (dominant arm). 
Testing Day 3 (approximately 3 hours):  
Testing Day 3 Procedures are identical to Testing Day 1 procedures with the 
exception of the hand-grip bout. The hand-grip bout will be replaced by a 
single bout of cuff inflation and deflation. You will have an inflatable cuff 
positioned on your non-dominant forearm below the elbow.  The cuff will be 
inflated above systolic BP and held at a constant pressure for 2 minutes, 
after which time the cuff will be released for 4 minutes.  This sequence will 
be repeated 4 times in a row to complete the bout so to mimic what occurs 
during the hand grip exercise.  This protocol should produce minimal 
discomfort as the duration and pressure is well below what has been found to 
cause even low discomfort.  
POTENTIAL RISKS AND DISCOMFORTS 
You may experience tendonitis in the tendons of the exercising arms with 
handgrip exercise however this risk is minimal if the exercise is properly 
performed. The blood pressure and blood flow measurement procedures are 
non-invasive but you may experience numbness and/or tingling in the limb 
with the cuff(s) while we are taking our measurements. The gel used to 
image your blood vessels and/or the sticker-electrodes used to measure your 
heart rate may cause a skin irritation however, this risk is minimal. 
Please contact one of the study investigators if you feel any adverse effects 
from completing any portion of the study, and/or if you have any questions 
or concerns. Exercise leaders and study investigators will reinforce proper 
exercise technique throughout the study. If you experience any adverse 
effects during any testing procedure, first line response will be provided.  
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POTENTIAL BENEFITS TO SUBJECTS AND/OR TO SOCIETY 
You may or may NOT experience a lower blood pressure at rest or during 
your activities of daily life after each part of the study. In addition, you may 
or may not have improvements in the ability of your heart to vary its rhythm, 
a decrease in the activity of your nervous system, reduced tension in certain 
blood vessels of your body, an increase in the efficiency of the work of your 
heart, and/or reduced oxidative stress. 
If we prove our theories, isometric handgrip training may be a possible 
prevention and/or treatment option for older males and females, like you. 
PAYMENT FOR PARTICIPATION 
You will receive a Human Kinetics T-shirt for your participation, and will be 
reimbursed for health care provider forms and/or parking costs over the 
course of the study. 
CONFIDENTIALITY 
Any information that is obtained in connection with this study and that can 
be identified with you will remain confidential and will be disclosed only 
with your permission. 
To ensure your confidentiality, following your consent, you will be assigned 
an identification number. Your name will not be mentioned in any 
publication or presentation, and you will be identified with only your 
identification number on all collection tools (electronic or otherwise). All 
paper data and all electronic data will be stored in the locked laboratory 
(PACR Lab, Room #240, Human Kinetics Building, University of Windsor) 
of the study investigators. Information stored on computer will be password-
accessible only. With respect to final disposal, all paper records (including 
medical and physical activity readiness questionnaires) will be shredded. 
PARTICIPATION AND WITHDRAWAL 
You can choose whether to be in this study or not.  If you volunteer to be in 
this study, you may withdraw at any time without consequences of any kind. 
You may also refuse to answer any questions you do not wish to answer and 
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still remain in the study.  The investigator may withdraw you from this 
research if circumstances arise which warrant doing so (e.g., medication, 
nutrition and/or physical activity change).   
FEEDBACK OF THE RESULTS OF THIS STUDY TO THE 
PARTICIPANTS 
You will have the option of receiving results from the study either verbally, 
by mail or email. Results will also be posted on the University of Windsor’s 
Research Ethics Board (REB) website (http://www.uwindsor.ca/reb) at the 
completion of the study. 
SUBSEQUENT USE OF DATA 
This data may be used in subsequent studies however your privacy will be 
upheld with the use of your unique subject identification number under all 
circumstances.  
RIGHTS OF RESEARCH PARTICIPANTS 
You may withdraw your consent at any time and discontinue participation 
without penalty. If you have questions regarding your rights as a research 
subject, contact:  Research Ethics Coordinator, University of Windsor, 
Windsor, Ontario, N9B 3P4; Telephone: 519-253-3000, ext. 3948; e mail: 
ethics@uwindsor.ca 
SIGNATURE OF RESEARCH PARTICIPANT/LEGAL 
REPRESENTATIVE 
I understand the information provided for the study: Gender differences in 
the vascular response to acute IHG exercise as described herein.  My 
questions have been answered to my satisfaction, and I agree to participate 
in this study.  I have been given a copy of this form. 
 
___________________________________ 
Name of Participant 
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___________________________________   ______________ 
Signature of Participant      Date 
 
SIGNATURE OF INVESTIGATOR 
These are the terms under which I will conduct research. 
___________________________________  ____________________ 
Signature of Investigator      Date 
 
 
 
 
 
 
 
Version Date: 03/12/13 
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Appendix B: LETTER OF INFORMATION  
 
LETTER OF INFORMATION 
Title of Study: Gender differences in the neurovascular response to 
acute isometric handgrip exercise and a complimentary ischemic-
reperfusion cuff protocol 
You are asked to participate in a research study conducted by Josh Seifarth, 
BHk, & Dr. Cheri McGowan, PhD, from the Department of Kinesiology at 
the University of Windsor. 
If you have any questions or concerns about the research, please feel to 
contact Josh Seifarth via telephone (519-253-3000 ext. 4979). 
PURPOSE OF THE STUDY 
 
Hypertension increases the risk of cardiovascular disease. Isometric 
handgrip exercise (constant squeeze) training is a type of exercise training 
that lowers blood pressure (BP) in people with and without high BP. The 
goal of this study is to see if men and women respond differently (i.e., blood 
pressure, heart rate, blood vessels) to a single bout of handgrip exercise. We 
will also see if inflating a cuff around your lower arm will have the same 
results as a single bout of handgrip exercise. 
 
Familiarization Session (30 minutes):  
In the familiarization session, you will be introduced to all the techniques 
that will be used in this study. To minimize anything that may influence 
results, we will ask you to refrain from the consumption of alcohol and 
participation in vigorous exercise for 24 hours prior to each testing session, 
and to avoid caffeine consumption for 12 hours prior. Further, we ask that 
you refrain from eating for 4 hours prior to all testing sessions. All testing 
will be conducted in a quiet, temperature-controlled room at the same time 
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of day. You will be asked to void their bladder prior to all testing sessions to 
minimize the effects of a full bladder on resting BP. 
The following testing days will be conducted in random order, and the 
testing measures within each day will also be in random order. 
Testing Day 1 (approximately 3 hours):   
First, your resting blood pressure will be measured in your upper arm after 
10 minutes of seated rest. Your blood pressure will be measured 4 times, 
with 2-minutes of rest between measures. This will repeated again at least 
24-hours after Testing Day 1.  
Next, while remaining seated, a blood pressure cuff will be placed on your 
non-dominant forearm. A technique called flow-mediated dilation will be 
used on your upper arm to measure the size of your artery and the speed of 
blood flowing through it.  To do this a probe with ultrasound gel will be 
placed on your upper arm. The cuff on your forearm will be inflated to 
~200mmHg for 5 minutes and then released.  Next, you will engage in 4 
bouts of handgrip exercise in your non-dominant arm comprising 2-minute 
squeezes with 4-minute breaks between each.  Following the exercise, 
measures of artery size and blood flow will be repeated.  You will then lie 
on your back for 30 minutes of rest.  
After 30 minutes of rest, blood vessel function will be measured using a 
technique called venous strain-gauge plethysmography.  In this procedure, 
your non-dominant arm will be elevated above heart level and a rubber 
strain gauge (similar to an elastic) will be placed around the largest part of 
your forearm. A cuff will be placed on your wrist and will be inflated to a 
pressure above systolic BP (generally close to 200mmHg).  The cuff on your 
upper arm will be inflated for 10 seconds and then released for 5 seconds, 
and this will continue for 1 minute.  Next, the upper arm cuff will be inflated 
to 200mmHg for 5 minutes and then released.  Forearm blood flow will be 
measured every 10 seconds for 1 minute after the cuff is released.  You will 
then engage in 4 bouts of handgrip exercise in your non-dominant arm 
comprising 2-minute squeezes with 4-minute breaks between each.  
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Following the exercise, the blood vessel function technique will be repeated 
as described above.  
Testing Day 2 (approximately 3 hours):  
Testing Day 2 will mirror Testing Day 1 with the following exception: 
testing measures will be performed in the non-exercised limb.  You will 
exercise using the same arm as Testing Day 1 (non-dominant arm), but we 
will measure all of our variables in your non-exercising arm (dominant arm). 
Testing Day 3 (approximately 3 hours):  
Testing Day 3 Procedures are identical to Testing Day 1 procedures with the 
exception of the hand-grip bout. The hand-grip bout will be replaced by a 
single bout of cuff inflation and deflation. You will have an inflatable cuff 
positioned on your non-dominant forearm below the elbow.  The cuff will be 
inflated above systolic BP and held at a constant pressure for 2 minutes, 
after which time the cuff will be released for 4 minutes.  This sequence will 
be repeated 4 times in a row to complete the bout so to mimic what occurs 
during the hand grip exercise.  This protocol should produce minimal 
discomfort as the duration and pressure is well below what has been found to 
cause even low discomfort.  
POTENTIAL RISKS AND DISCOMFORTS 
You may experience tendonitis in the tendons of the exercising arms with 
handgrip exercise however this risk is minimal if the exercise is properly 
performed. The blood pressure and blood flow measurement procedures are 
non-invasive but you may experience numbness and/or tingling in the limb 
with the cuff(s) while we are taking our measurements. The gel used to 
image your blood vessels and/or the sticker-electrodes used to measure your 
heart rate may cause a skin irritation however, this risk is minimal. 
Please contact one of the study investigators if you feel any adverse effects 
from completing any portion of the study, and/or if you have any questions 
or concerns. Exercise leaders and study investigators will reinforce proper 
exercise technique throughout the study. If you experience any adverse 
effects during any testing procedure, first line response will be provided.  
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POTENTIAL BENEFITS TO SUBJECTS AND/OR TO SOCIETY 
You may or may NOT experience a lower blood pressure at rest or during 
your activities of daily life after each part of the study. In addition, you may 
or may not have improvements in the ability of your heart to vary its rhythm, 
a decrease in the activity of your nervous system, reduced tension in certain 
blood vessels of your body, an increase in the efficiency of the work of your 
heart, and/or reduced oxidative stress. 
If we prove our theories, isometric handgrip training may be a possible 
prevention and/or treatment option for older males and females, like you. 
PAYMENT FOR PARTICIPATION 
You will receive a Human Kinetics T-shirt for your participation, and will be 
reimbursed for health care provider forms and/or parking costs over the 
course of the study. 
CONFIDENTIALITY 
Any information that is obtained in connection with this study and that can 
be identified with you will remain confidential and will be disclosed only 
with your permission. 
To ensure your confidentiality, following your consent, you will be assigned 
an identification number. Your name will not be mentioned in any 
publication or presentation, and you will be identified with only your 
identification number on all collection tools (electronic or otherwise). All 
paper data and all electronic data will be stored in the locked laboratory 
(PACR Lab, Room #240, Human Kinetics Building, University of Windsor) 
of the study investigators. Information stored on computer will be password-
accessible only. With respect to final disposal, all paper records (including 
medical and physical activity readiness questionnaires) will be shredded. 
PARTICIPATION AND WITHDRAWAL 
You can choose whether to be in this study or not.  If you volunteer to be in 
this study, you may withdraw at any time without consequences of any kind. 
You may also refuse to answer any questions you do not wish to answer and 
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still remain in the study.  The investigator may withdraw you from this 
research if circumstances arise which warrant doing so (e.g., medication, 
nutrition and/or physical activity change).   
FEEDBACK OF THE RESULTS OF THIS STUDY TO THE 
PARTICIPANTS 
You will have the option of receiving results from the study either verbally, 
by mail or email. Results will also be posted on the University of Windsor’s 
Research Ethics Board (REB) website (http://www.uwindsor.ca/reb) at the 
completion of the study. 
SUBSEQUENT USE OF DATA 
This data may be used in subsequent studies however your privacy will be 
upheld with the use of your unique subject identification number under all 
circumstances.  
RIGHTS OF RESEARCH PARTICIPANTS 
You may withdraw your consent at any time and discontinue participation 
without penalty. If you have questions regarding your rights as a research 
subject, contact:  Research Ethics Coordinator, University of Windsor, 
Windsor, Ontario, N9B 3P4; Telephone: 519-253-3000, ext. 3948; e mail: 
ethics@uwindsor.ca 
 
 
 
 
 
 
 
 
 
 
Version Date: 03/12/13 
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Appendix C: Medical Questionnaire 
	  
Last Name _______________________________________________   First Name ________________________________________  
Height:_______________________ Weight: _______________________ Date of Birth (Month/Yr) _______    
Phone   (             ) _______________________________________   Postal Code ____________________  
  
FOR EMERGENCY NOTIFY:  Name ___________________   Relationship ________________________________________ 
Address __________________________________________________________  Phone ____________________________________  
Family Doctor's Name _______________________________________   Date of Last Physical ________________________________  
 
Please Check Yes or No:                                                                                                                                        
Yes  No  
1. Have you ever been hospitalized? ............................................................................................................................ ❏ ❏  
        If yes, please specify? 
_______________________________________________________________________________________ 
 Have you ever had surgery? ..................................................................................................................................... ❏ ❏ 
         If yes, please specify? 
_______________________________________________________________________________________ 
2. Are you presently taking any medications or pills (including aspirin and other over-the-counter 
medication)? ❏ ❏ 
   If yes, please specify? 
_______________________________________________________________________________________ 
 Are you presently taking any vitamins, supplements, and/or herbal supplements? .................................................. ❏ ❏ 
3. Do you have any allergies (medicine, food, bees or other stinging insects)? ............................................................ ❏ ❏ 
   If yes, please specify? 
_______________________________________________________________________________________  
4. Have you ever passed out during or after exercise? ................................................................................................. ❏ ❏ 
 Have you ever been dizzy during or after exercise? ................................................................................................. ❏ ❏ 
 Have you ever had chest pain during or after exercise? ........................................................................................... ❏ ❏ 
 Do you have high blood pressure (hypertension) or low blood pressure (hypotension)? .......................................... ❏ ❏ 
       Have you ever been told that you have a kidney problem?  ...................................................................................... ❏ ❏ 
 Have you ever been told that you have joint instability?  ........................................................................................... ❏ ❏ 
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       Have you ever been told that you have a stomach problem?  ................................................................................... ❏ ❏ 
       Have you ever been told that you have a heart problem?  ........................................................................................ ❏ ❏ 
       Have you ever been told that you have a heart murmur? .......................................................................................... ❏ ❏ 
 Do you have a machine that regulated your heart beat?  .......................................................................................... ❏ ❏ 
       Have you ever had racing of your heart or skipped heartbeats? ............................................................................... ❏ ❏ 
 Has anyone in your family died of heart problems or a sudden death before age 50? ............................................. ❏ ❏ 
5. Do you have any skin problems (itching, rashes, acne)? .......................................................................................... ❏ ❏ 
       If you get a cut, does it take you a long time to stop bleeding? ................................................................................. ❏ ❏  
 If you experience a blow to a muscle, to you bruise easily?  ..................................................................................... ❏ ❏  
6. Do you have Diabetes?     ......................................................................................................................................... ❏ ❏ 
7. Do you have Asthma or any other breathing problems?       ..................................................................................... ❏ ❏ 
               If yes, please specify? 
_______________________________________________________________________________________ 
8. Do you have any type of cardiovascular disease? .................................................................................................... ❏ ❏ 
    If yes, please 
specify?_______________________________________________________________________________________ 
9. Have you had any other medical problems (infectious mononucleosis, etc.)? .......................................................... ❏ ❏ 
10. Have you had any medical problems since your last physical? ................................................................................ ❏ ❏ 
11. Do you smoke?                  ......................................................................................................................................... ❏ ❏ 
12.  Do you aerobically exercise (e.g., walking) for > 30 minutes, > 2 times per week?  ................................................. ❏ ❏ 
Please explain any physical limitations that may prevent you from completing this study: 
  __________________________________________________________________________________________________  
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Appendix D: Resting BP Device 
 
Dinamap Carescape v100, Critikon, Tampa, Florida, USA 
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Appendix E: Physical Activity Readiness Medical Examination (PAR MED-X) 
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Appendix F: Physical Activity Readiness Questionnaire (PAR-Q) 
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Appendix G: Healthcare Provider Form 
	   	   	   	   	   	   	   	   	   	  	  	  	  	  	  
 
Date:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  .	  
	  
Dear	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ,	  
	  
Your	  patient,	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ,	  has	  expressed	  
interest	  in	  participating	  in	  our	  research	  study	  in	  the	  Department	  of	  
Kinesiology	  at	  the	  University	  of	  Windsor	  entitled:	  	  Gender	  differences	  in	  the	  
vascular	  response	  to	  acute	  IHG	  exercise	  (see	  attached	  Letter	  of	  Information	  
for	  Consent	  for	  details).	  	  If	  you	  approve	  your	  patient’s	  participation	  in	  our	  
study	  (via	  PAR-­‐medX),	  we	  kindly	  request	  that	  you	  or	  a	  representative	  
inform	  us	  of	  any	  changes	  in	  medically-­‐endorsed	  exercise,	  nutrition	  and/or	  
medication	  status,	  as	  these	  changes	  may	  influence	  our	  findings.	  	  We	  ask	  
that	  you	  sign	  the	  attached	  form	  for	  return	  with	  the	  PAR	  Med-­‐X	  to	  
acknowledge	  your	  receipt	  of	  this	  request.	  
Thank	  you	  for	  your	  help,	  and	  we	  appreciate	  your	  support.	  	  Please	  do	  not	  
hesitate	  to	  contact	  us	  if	  you	  have	  any	  questions	  or	  concerns.	  
	  
Sincerely,	  
Dr.	  Cheri	  McGowan,	  Ph.D	  
Assistant	  Professor	  
Department	  of	  Kinesiology	  
Faculty	  of	  Human	  Kinetics	  
University	  of	  Windsor	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Appendix H: ECG & PowerLab (Data Recording Device) 
 
  
 
Powerlab ML 870/P, AD Instruments, Colorado Springs, Colorado, USA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
M.H.K. Thesis – J. Seifarth University of Windsor – Applied Human Performance 
	   114	  
Appendix I: Ultrasound Machine 
 
 
 
Vivid i, GE Healthcare, Pittsburgh, Pennsylvania, USA 
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Appendix J:  Isometric Handgrip 
 
 
 
ZonaPLUS, Zona HEALTH, Boise, Idaho, USA 
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Appendix K: Plethysmography System 
 
 
 
Hokanson EC6 Strain Gauge and Photo Plethysmograph, D.E. Hokanson, Inc., Bellevue, 
WA, USA 
 
 
 
 
 
 
 
 
 
 
M.H.K. Thesis – J. Seifarth University of Windsor – Applied Human Performance 
	   117	  
Appendix L: Hokanson Inflatable Cuff 
 
 
 
 
 
 
Hokanson E20 Cuff Inflator, D.E. Hokanson, Inc., Bellevue, Washington, USA 
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Appendix M: Recruitment Script & Poster 
 
Local media/newspaper/email recruitment script: 
" Attention all men and women over the age of 60 years with normal blood 
pressure. You may be eligible to participate in a research study at the University 
of Windsor being conducted by Josh Seifarth, BHK and Dr. Cheri McGowan, 
PhD. We are investigating the effects of a single bout of isometric handgrip 
exercise on your blood pressure, heart rate and blood vessels. For more 
information please contact Josh Seifarth at 519-253-3000 ex. 4979 
or seifart@uwindsor.ca." 
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Josh	  Seifarth,	  BHK,	  and	  Dr.	  Cheri	  McGowan,	  PhD,	  at	  the	  University	  of	  Windsor	  is	  
currently	  looking	  for	  individuals	  over	  the	  age	  of	  60	  years	  with	  normal	  blood	  pressure	  
to	  participate	  in	  a	  study	  examining	  the	  effects	  of	  isometric	  handgrip	  exercise	  on	  blood	  
pressure,	  heart	  rate	  and	  blood	  vessels.	  
If	  you	  are	  interested	  and	  would	  like	  more	  information	  please	  contact	  
Josh	  Seifarth,	  BHK:	  (519)-­‐253-­‐3000	  ext.	  4979	  or	  seifart@uwindsor.ca	  
This	  study	  has	  been	  cleared	  by	  the	  University	  of	  Windsor’s	  Research	  Ethics	  Board	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Appendix N: Emergency Action Plan (EAP) 
 
EMERGENCY	  ACTION	  PLAN	  (EAP)	  
FOR	  MEDICAL	  EMERGENCIES	  DURING	  EXERCISE	  TESTING	  
	  
	  
	  
	  
STEP	  1:	  	   REMAIN	  CALM.	  	  	  
CONTROL	  and	  ASSESS	  the	  situation.	  
Campus	  Police	  EXT.	  4444	  	  	  	  	  	  	  	  	  	  	  	  	  	  OR	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  911	  (they	  will	  dispatch	  required	  authorities)	  	  	  	  OUR	  ADDRESS/DIRECTIONS:	  
The	  University	  of	  Windsor	  
Human	  Kinetics	  Building	  
2555	  College	  Ave.	  Main	  Entrance	  off	  College	  Ave.	  	  
Room#	  240	  (uppermost	  floor)	  Go	  in	  through	  the	  main	  doors	  of	  the	  Human	  Kinetics	  Building.	  There	  will	  be	  doors	  on	  the	  left	  hand	  side.	  Go	  Up	  the	  stairs,	  and	  go	  to	  the	  end	  of	  the	  hallway.	  Turn	  left	  and	  walk	  to	  the	  end	  of	  the	  short	  hallway,	  turn	  left,	  room	  240	  will	  be	  the	  first	  door	  on	  your	  right	  hand	  side.	  
	   	   	   OUR	  PHONE#:	  	  	  
519-­‐253-­‐3000	  ext.4979	  
STEP	  2:	  	   PERFORM	  all	  measures	  (CPR/First	  Aid)	  to	  ensure	  safety	  of	  subject.	  
	   	   ATTEND	  to	  subject	  until	  replaced	  by	  emergency	  personnel.	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Appendix O: Raw Data for Chapter 2 
Participant Characteristics 
Participant Characteristics 
Participant Age (years) Sex Height (cm) Weight (kg) BMI (kg/m2) 
1 63 M 180.3 73.9 22.7 
2 63 F 156.2 72.6 29.8 
3 63 F 160.0 67.1 26.2 
4 68 F 162.6 65.8 24.9 
5 72 F 157.5 53.5 21.6 
6 63 F 170.2 65.8 22.7 
7 59 F 167.6 73.5 26.2 
8 64 F 154.9 79.4 33.1 
            
Resting Systolic Blood Pressure Data (mmHg) 
  Testing Day 
Participant IV FAM CUFF E IHG NE IHG 
1 108.0 101.3 122.0 88.3 97.0 
2 102.0 97.7 98.3 96.7 95.7 
3 102.3 136.0 114.0 96.7 100.3 
4 96.3 100.7 84.3 85.0 85.3 
5 106.7 94.3 91.3 93.7 90.3 
6 99.0 104.3 94.7 98.0 100.3 
7 99.3 105.3 100.7 96.7 110.3 
8 110.7 101.3 112.3 108.7 105.7 
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Resting Diastolic Blood Pressure Data (mmHg) 
  Testing Day 
Participant IV FAM CUFF E IHG NE IHG 
1 64.7 70.7 78.3 60.7 65.7 
2 61.7 60.7 57.7 68.0 64.3 
3 56.7 65.3 64.3 54.7 59.0 
4 54.3 58.3 54.7 53.3 50.0 
5 58.7 57.7 58.3 61.3 55.7 
6 63.7 65.3 60.0 62.7 64.0 
7 64.0 61.0 62.3 61.3 63.0 
8 65.3 70.7 62.3 56.3 57.7 
            
Mean Arterial Pressure Data (mmHg) 
  Testing Day 
Participant IV FAM CUFF E IHG NE IHG 
1 79.1 80.9 92.9 69.9 76.1 
2 75.1 73.0 71.2 77.6 74.8 
3 71.9 88.9 80.9 68.7 72.8 
4 68.3 72.4 64.6 63.9 61.8 
5 74.7 69.9 69.3 72.1 67.2 
6 75.4 78.3 71.6 74.4 76.1 
7 75.8 75.8 75.1 73.1 78.8 
8 80.4 80.9 79.0 73.8 73.7 
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Resting Heart Data (bpm) 
  Testing Day 
Participant IV FAM CUFF E IHG NE IHG 
1 56.0 69.7 60.0 59.0 57.3 
2 77.0 74.7 77.3 75.0 74.0 
3 65.3 60.3 64.3 70.0 71.3 
4 74.0 76.0 66.7 68.3 69.7 
5 74.3 67.3 73.3 70.3 73.3 
6 68.7 69.0 74.0 75.0 66.0 
7 70.7 62.0 63.0 63.3 68.0 
8 62.0 69.7 66.3 58.3 57.3 
 
 
Resting and Peak Blood Flow Data 
Pre CUFF Testing Flows Female 
Participant Resting Flow (cm/s) Peak Flow (cm/s) 
2 22.22519733 404.5078673 
3 20.35982427 382.7482208 
4 23.99261081 220.9790071 
5 47.81266657 570.7514923 
6 73.14511132 366.1467813 
7 18.4721024 279.9516878 
8 21.63822891 709.7212716 
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Pre EIHG Testing Flows Female 
Participant Resting Flow (cm/s) Peak Flow (cm/s) 
2 14.60205232 205.5673214 
3 19.59163852 434.3219139 
4 28.77236416 581.7644794 
5 48.13869258 847.6186324 
6 31.1149305 413.5066312 
7 28.10489987 304.8371524 
8 68.35749489 460.7339396 
   
Pre NEIHG Testing Flows Female 
Participant Resting Flow (cm/s) Peak Flow (cm/s) 
2 22.29328193 425.2542218 
3 21.63324871 376.0325289 
4 25.33594238 403.88686 
5 45.90914855 561.0371047 
6 53.16600149 265.6374032 
7 18.11859245 391.7234726 
8 49.63268045 535.50808 
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Post CUFF Testing Flows Female 
Participant Resting Flow (cm/s) Peak Flow (cm/s) 
2 17.73813899 270.1877329 
3 21.42480324 356.5324867 
4 20.83494608 327.5638129 
5 23.27570226 435.5061611 
6 91.06042693 528.5279628 
7 19.57201412 320.3457525 
8 25.25685597 424.5895606 
   
Post EIHG Testing Flows Female 
Participant Resting Flow (cm/s) Peak Flow (cm/s) 
2 56.16773976 246.2693679 
3 33.79627911 377.0957874 
4 22.34190045 605.5760602 
5 27.60999991 624.277575 
6 41.10740014 416.1127884 
7 27.95703032 368.7801058 
8 46.62203405 487.0128601 
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Post NEIHG Testing Flows Female 
Participant Resting Flow (cm/s) Peak Flow (cm/s) 
2 17.11948178 257.0308573 
3 26.2993078 482.7056463 
4 18.87184917 313.8152303 
5 30.25820127 728.2940992 
6 25.25452248 477.5617903 
7 21.06789363 375.2653923 
8 37.44781531 661.9019017 
 
Pre CUFF Testing Flows Male 
Participant Resting Flow (cm/s) Peak Flow (cm/s) 
1 188.0804487 1054.058321 
   
Pre EIHG Testing Flows Male 
Participant Resting Flow (cm/s) Peak Flow (cm/s) 
1 217.2368179 1072.10085 
   
Pre NEIHG Testing Flows Male 
Participant Resting Flow (cm/s) Peak Flow (cm/s) 
1 68.0977749 967.7796548 
 
Post CUFF Testing Flows Male 
Participant Resting Flow (cm/s) Peak Flow (cm/s) 
1 123.6441267 1114.223419 
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Post EIHG Testing Flows Male 
Participant Resting Flow (cm/s) Peak Flow (cm/s) 
1 168.586634 964.9555118 
   
Post NEIHG Testing Flows Male 
Participant Resting Flow (cm/s) Peak Flow (cm/s) 
1 102.3508548 733.0389512 
 
 
Resting Diameter, Peak Diameter, and Flow-Mediated Dilation Data 
Pre CUFF Testing FMD Female 
Participant  
Resting Diameter 
(mm) 
Peak Diameter 
(mm) 
FMD Absolute 
(mm) 
Non-Normalized 
FMD Relative 
(%) 
2 2.3242 2.858 0.5338 22.96704242 
3 2.6812 2.8473 0.1661 6.194987319 
4 2.8376 2.926 0.0884 3.115308712 
5 3.4228 3.8877 0.4649 13.58244712 
6 2.9678 3.2867 0.3189 10.74533324 
7 2.9076 3.0443 0.1367 4.701472004 
8 3.1154 3.5743 0.4589 14.73005072 
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Pre EIHG Testing FMD Female 
Participant  
Resting Diameter 
(mm) 
Peak Diameter 
(mm) 
FMD Absolute 
(mm) 
Non-Normalized 
FMD Relative 
(%) 
2 2.1224 2.5393 0.4169 19.64285714 
3 2.6128 2.9745 0.3617 13.84338641 
4 2.8872 3.9437 1.0565 36.59254641 
5 3.4878 4.8547 1.3669 39.19089397 
6 3.1057 3.2863 0.1806 5.815114145 
7 2.9293 3.21 0.2807 9.582494111 
8 3.4487 3.4605 0.0118 0.342157915 
     
Pre NEIHG Testing FMD Female 
Participant  
Resting Diameter 
(mm) 
Peak Diameter 
(mm) 
FMD Absolute 
(mm) 
Non-Normalized 
FMD Relative 
(%) 
2 2.9457 3.3747 0.429 14.56360118 
3 2.7104 3.5517 0.8413 17.20410272 
4 2.9095 3.3167 0.4072 13.99553188 
5 3.9078 3.988 0.0802 2.052305645 
6 3.03675 3.095 0.05825 0.019181691 
7 2.8101 3.0547 0.2446 8.704316572 
8 3.362 3.4393 0.0773 2.299226651 
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Post CUFF Testing FMD Female 
Participant  
Resting Diameter 
(mm) 
Peak Diameter 
(mm) 
FMD Absolute 
(mm) 
Non-Normalized 
FMD Relative 
(%) 
2 2.3633 2.9017 0.5384 22.78170355 
3 2.7064 2.8693 0.1629 6.019065918 
4 2.7724 3 0.2276 8.20949358 
5 3.4544 3.701 0.2466 7.13872163 
6 2.8989 3.3313 0.4324 14.91600262 
7 2.7911 2.8907 0.0996 3.568485543 
8 3.4373 3.1407 -0.2966 -8.628865679 
     
Post EIHG Testing FMD Female 
Participant  
Resting Diameter 
(mm) 
Peak Diameter 
(mm) 
FMD Absolute 
(mm) 
Non-Normalized 
FMD Relative 
(%) 
2 2.5347 2.4783 -0.0564 -2.225115398 
3 2.6277 2.8103 0.1826 6.949042889 
4 2.7241 3.7595 1.0354 38.00888367 
5 3.3155 4.0787 0.7632 23.01915247 
6 3.0084 3.4393 0.4309 14.32322829 
7 2.9966 3.1883 0.1917 6.397250217 
8 3.2932 3.515 0.2218 6.735090489 
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Post NEIHG Testing FMD Female 
Participant  
Resting Diameter 
(mm) 
Peak Diameter 
(mm) 
FMD Absolute 
(mm) 
Non-Normalized 
FMD Relative 
(%) 
2 2.817 2.9943 0.1773 6.293929712 
3 2.7487 3.0203 0.2716 9.881034671 
4 2.9071 3.1957 0.2886 9.927419077 
5 3.7906 3.8293 0.0387 1.020946552 
6 3.1089 3.2127 0.1038 3.338801505 
7 2.7402 3.199 0.4588 16.74330341 
8 3.2487 3.476 0.2273 6.996644812 
 
Pre CUFF Testing FMD Male 
Participant  
Resting Diameter 
(mm) 
Peak Diameter 
(mm) 
FMD Absolute 
(mm) 
Non-Normalized 
FMD Relative 
(%) 
1 4.9424 4.942 -0.0004 -0.008093234 
     
Pre EIHG Testing FMD Male 
Participant  
Resting Diameter 
(mm) 
Peak Diameter 
(mm) 
FMD Absolute 
(mm) 
Non-Normalized 
FMD Relative 
(%) 
1 5.0536 4.8643 -0.1893 -3.745844546 
     
Pre NEIHG Testing FMD Male 
Participant  
Resting Diameter 
(mm) 
Peak Diameter 
(mm) 
FMD Absolute 
(mm) 
Non-Normalized 
FMD Relative 
(%) 
1 5.0748 5.143 0.0682 1.343895326 
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Post CUFF Testing FMD Male 
Participant  
Resting Diameter 
(mm) 
Peak Diameter 
(mm) 
FMD Absolute 
(mm) 
Non-Normalized 
FMD Relative 
(%) 
1 4.7075 5.1787 0.4712 10.00955921 
     
Post EIHG Testing FMD Male 
Participant  
Resting Diameter 
(mm) 
Peak Diameter 
(mm) 
FMD Absolute 
(mm) 
Non-Normalized 
FMD Relative 
(%) 
1 4.7855 5.5133 0.7278 15.20844217 
     
Post NEIHG Testing FMD Male 
Participant  
Resting Diameter 
(mm) 
Peak Diameter 
(mm) 
FMD Absolute 
(mm) 
Non-Normalized 
FMD Relative 
(%) 
1 5.3078 4.951 -0.3568 -6.722182448 
 
 
Resting and Peak Shear Data 
Pre CUFF Shear Flows Female 
Participant Resting Shear (s-1) Peak Shear (s-1) 
2 30.05204222 361.7244643 
3 17.93226913 298.9278434 
4 17.82677726 154.4187576 
5 20.24171244 187.2961708 
6 47.5040097 193.887279 
7 12.75737149 176.3690558 
8 12.14868075 302.719822 
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Pre EIHG Testing Shear Female 
Participant Resting Shear (s-1) Peak Shear (s-1) 
2 25.92871801 255.0043975 
3 18.64666258 318.9528475 
4 20.29522154 219.9436594 
5 19.26142554 175.05438 
6 17.63352688 209.2943083 
7 18.98188522 171.4521103 
8 28.29233181 189.3938779 
   
Pre NEIHG Testing Shear Female 
Participant Resting Shear (s-1) Peak Shear (s-1) 
2 14.80666735 215.1981985 
3 18.44465059 233.3933491 
4 17.4634817 214.2287907 
5 13.0602385 153.2490574 
6 32.22966073 155.0271398 
7 13.86142842 253.6118525 
8 22.172949 228.6004362 
 
Post CUFF Shear Flows Female 
Participant Resting Shear (s-1) Peak Shear (s-1) 
2 22.81394257 230.5104444 
3 18.34804273 271.6464676 
4 16.5986805 222.8673111 
5 9.585919407 156.2544388 
6 63.45689744 278.9048721 
7 15.28122553 233.1773614 
8 10.55785829 212.5924417 
 	   	  
Post EIHG Shear Flows Female 
Participant Resting Shear (s-1) Peak Shear (s-1) 
2 58.55393801 268.5498613 
3 31.62207761 308.4745848 
4 18.76289417 267.0141821 
5 12.86080531 192.1471875 
6 25.63079787 198.5108363 
7 17.63817175 205.527153 
8 22.16081623 203.1985101 
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Post NEIHG Shear Flows Female 
Participant Resting Shear (s-1) Peak Shear (s-1) 
2 13.00106496 172.7653532 
3 21.49864785 326.8163132 
4 13.04017437 179.4448075 
5 9.431224608 222.4379606 
6 14.268153 252.6569955 
7 17.38293821 227.1834173 
8 18.54157047 286.2683535 
 
 
Normalized Flow-Mediated Dilation to Area-Under-Curve Data 
Normalized FMD Pre CUFF Female 
Participant AUC (s^-1) 
FMD (% 
Change) 
Normalized FMD 
(FMD:AUC) 
2 5812.3165 22.96704242 3.951443873 
3 5031.7688 6.194987319 1.231174874 
4 430.9138 3.115308712 7.229540367 
5 3938.7774 13.58244712 3.448391656 
6 2956.0875 10.74533324 3.634984838 
7 2859.1754 4.701472004 1.644345431 
8 9186.8551 14.73005072 1.603383373 
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Normalized FMD Pre EIHG Female 
Participant AUC (s^-1) 
FMD (% 
Change) 
Normalized FMD 
(FMD:AUC) 
2 1892.3211 19.64285714 10.38029811 
3 7845.7111 13.84338641 1.764452735 
4 4164.2788 36.59254641 8.787247005 
5 979.6796 10.5195252 10.73771997 
6 5102.4433 5.815114145 1.139672467 
7 3102.5985 9.582494111 3.08853824 
8 6153.2461 0.342157915 0.055606083 
    
 Normalized FMD Pre NEIHG Female 
Participant AUC (s^-1) 
FMD (% 
Change) 
Normalized FMD 
(FMD:AUC) 
2 679.2549 14.56360118 21.44055373 
3 1597.6749 17.20410272 10.76821243 
4 3096.7299 13.99553188 4.519455145 
5 2118.9745 2.052305645 0.968537208 
6 225.3807 0.019181691 0.085107957 
7 754.1978 8.704316572 11.54115879 
8 8992.5004 2.299226651 0.255682685 
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Normalized FMD Post CUFF Female 
Participant AUC (s^-1) 
FMD (% 
Change) 
Normalized FMD 
(FMD:AUC) 
2 2835.0948 22.78170355 8.035605564 
3 1759.0219 6.019065918 3.421825458 
4 2842.9362 8.20949358 2.887681257 
5 1076.4615 7.13872163 6.631655317 
6 8317.5512 14.91600262 1.793316598 
7 2480.3568 8.54860091 3.446520642 
8 4438.903 -5.419951706 -1.221011522 
    
 Normalized FMD Post EIHG Female 
Participant AUC (s^-1) 
FMD (% 
Change) 
Normalized FMD 
(FMD:AUC) 
2 5623.3676 -2.225115398 -0.395690902 
3 9017.9755 6.949042889 0.770576821 
4 3862.8437 38.00888367 9.839612115 
5 3641.2896 23.01915247 6.321703296 
6 1929.4074 14.32322829 7.423641214 
7 2495.8424 6.397250217 2.563162729 
8 4346.8623 6.735090489 1.549414273 
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Normalized FMD Post NEIHG Female 
Participant AUC (s^-1) 
FMD (% 
Change) 
Normalized FMD 
(FMD:AUC) 
2 1987.3845 6.293929712 3.166941129 
3 6375.3274 9.881034671 1.549886626 
4 3230.7513 9.927419077 3.072789626 
5 1927.8325 1.020946552 0.529582602 
6 2350.3771 3.338801505 1.420538647 
7 2370.1924 16.74330341 7.064111508 
8 4763.426 6.996644812 1.468826179 
 
Normalized FMD Pre CUFF Male 
Participant AUC (s^-1) 
FMD (% 
Change) 
Normalized FMD 
(FMD:AUC) 
1 4360.5706 -0.008093234 -0.001856003 
    
Normalized FMD Pre EIHG Male 
Participant AUC (s^-1) 
FMD (% 
Change) 
Normalized FMD 
(FMD:AUC) 
1 1814.5938 -3.745844546 -2.064288188 
    
Normalized FMD Pre NEIHG Male 
Participant AUC (s^-1) 
FMD (% 
Change) 
Normalized FMD 
(FMD:AUC) 
1 3498.6218 1.343895326 0.384121349 
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Normalized FMD Post CUFF Male 
Participant AUC (s^-1) 
FMD (% 
Change) 
Normalized FMD 
(FMD:AUC) 
1 2319.6843 10.00955921 4.31505236 
    
Normalized FMD Post EIHG Male 
Participant AUC (s^-1) 
FMD (% 
Change) 
Normalized FMD 
(FMD:AUC) 
1 2691.0906 15.20844217 5.651404739 
    
Normalized FMD Post NEIHG Male 
Participant AUC (s^-1) 
FMD (% 
Change) 
Normalized FMD 
(FMD:AUC) 
1 2133.3905 -6.722182448 -3.150938587 
 
 
Resistance Vessel Function Plethysmography Data 
  Pre NEIHG (ml/min/100mL) 
Participant Pre1 Pre2 Pre3 PreAVG Post 
1 NA NA NA NA NA 
2 NA NA NA NA NA 
3 11.80039 18.5501 12.04631 14.13226667 47.09532 
4 0.84006 1.93445 1.63782 1.470776667 5.82215 
5 3.31918 3.90108 3.45281 3.55769 43.17275 
6 8.29485 6.02313 3.05427 5.79075 39.6503 
7 4.48572 8.80818 7.40931 6.90107 28.40552 
8 8.6471 7.29131 5.1879 7.042103333 41.76925 
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  Pre EIHG (ml/min/100mL) 
Participant Pre1 Pre2 Pre3 PreAVG Post 
1 NA NA NA NA NA 
2 NA NA NA NA NA 
3 20.2617 42.9035 32.82851 31.99790333 66.83889 
4 6.01138 6.4931 5.82604 6.110173333 26.12393 
5 14.72074 10.00891 10.02425 11.58463333 77.38969 
6 13.01243 9.7227 5.40492 9.380016667 45.4065 
7 7.54566 5.73339 4.1882 5.822416667 26.28721 
8 5.2134 6.32424 2.85904 4.798893333 50.08815 
     
 
 
       
  Pre CUFF (ml/min/100mL) 
Participant Pre1 Pre2 Pre3 PreAVG Post 
1 NA NA NA NA NA 
2 3.32829 2.64789 1.74952 2.575233333 38.10101 
3 2.24736 2.10095 1.65911 2.002473333 46.1206 
4 7.45178 10.1916 9.57748 9.07362 23.05956 
5 7.68731 4.95402 6.7541 6.465143333 46.33809 
6 5.06635 3.86301 5.13548 4.68828 45.69986 
7 2.44427 1.94474 2.53613 2.30838 41.53496 
8 2.89552 2.57575 3.27492 2.915396667 34.83446 
       
  
Post NEIHG (ml/min/100mL) 
Participant Pre1 Pre2 Pre3 PreAVG Post 
1 NA NA NA NA NA 
2 NA NA NA NA NA 
3 4.70431 6.96192 7.93385 6.53336 58.8782 
4 4.321385 4.082782 1.640562 3.348243 35.80695 
5 10.72153 10.64342 13.5788 11.64792 106.1506 
6 2.7511 3.57957 2.89176 3.074143333 43.05418 
7 1.29277 4.07373 4.66594 3.344146667 32.47578 
8 7.52166 6.67188 6.1386 6.77738 33.91461 
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  Post EIHG (ml/min/100mL) 
Participant Pre1 Pre2 Pre3 PreAVG Post 
1 NA NA NA NA NA 
2 NA NA NA NA NA 
3 17.55736 12.71173 8.84376 13.03761667 53.45543 
4 10.10476 12.93273 12.70704 11.91484333 31.34942 
5 7.60458 8.81746 9.41001 8.610683333 70.57919 
6 12.73225 22.50849 9.72716 14.9893 23.19122 
7 7.5286 8.23375 8.23236 7.998236667 40.37915 
8 10.70901 11.0428 12.142 11.29793667 50.67992 
       
  Post CUFF (ml/min/100mL) 
Participant Pre1 Pre2 Pre3 PreAVG Post 
1 NA NA NA NA NA 
2 2.74114 2.61477 1.8213 2.392403333 32.99766 
3 3.2693 3.9803 5.45247 4.234023333 39.13814 
4 19.0933 12.4226 14.5353 15.3504 28.83334 
5 15.25128 14.48485 12.56437 14.10016667 76.01387 
6 5.1017 6.77356 4.39923 5.42483 52.4203 
7 1.77377 1.88094 2.0721 1.908936667 27.34554 
8 0.94592 8.32322 9.2521 6.173746667 66.09124 
 
*All missing data for participant 1 and 2 was due to equipment malfunction at the time of 
testing. 
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Appendix P: Statistics for Chapter 2 
Resting SBP 
One Way Repeated Measures Analysis of Variance Monday, October 21, 2013 
Data source: Data 1 in Resting SBP.JNB 
Normality Test (Shapiro-Wilk) Passed (P = 0.100) 
Equal Variance Test: Passed (P = 0.466) 
 
Treatment Name  N  Missing Mean Std Dev SEM  
Rest IV 7 0 102.333 4.907 1.854 
Rest Fam 7 0 105.667 13.894 5.251 
Rest CUFF 7 0 99.381 10.783 4.076 
Rest EIHG 7 0 96.476 6.960 2.631 
Rest NEIHG 7 0 98.286 8.620 3.258 
 
Source of Variation  DF   SS   MS    F    P   
Between Subjects 6 1410.394 235.066    
Between Treatments 4 366.635 91.659 1.658 0.192  
Residual 24 1326.432 55.268    
Total 34 3103.460     
 
Power of performed test with alpha = 0.050: 0.181 
 
 
 
Resting DBP 
One Way Repeated Measures Analysis of Variance Monday, October 21, 2013 
Data source: Data 1 in Resting DBP.JNB 
Normality Test (Shapiro-Wilk) Passed (P = 0.388) 
Equal Variance Test: Passed (P = 0.252) 
 
Treatment Name  N  Missing Mean Std Dev SEM  
Rest IV 7 0 60.619 4.143 1.566  
Rest Fam 7 0 62.714 4.633 1.751  
Rest CUFF 7 0 59.952 3.325 1.257  
Rest EIHG 7 0 59.667 5.168 1.953  
REST NEIHG 7 0 59.095 5.216 1.972  
 
Source of Variation  DF   SS   MS    F    P   
Between Subjects 6 317.263 52.877    
Between Treatments 4 54.908 13.727 1.083 0.387  
Residual 24 304.292 12.679    
Total 34 676.463     
 
Power of performed test with alpha = 0.050: 0.063 
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Resting MAP 
One Way Repeated Measures Analysis of Variance Monday, October 21, 2013 
Data source: Data 1 in Resting MAP.JNB 
Normality Test (Shapiro-Wilk) Passed (P = 0.742) 
Equal Variance Test: Passed (P = 0.688) 
 
Treatment Name  N  Missing Mean Std Dev SEM  
Rest IV 7 0 74.524 3.722 1.407  
Rest Fam 7 0 77.032 6.417 2.425  
Rest CUFF 7 0 73.095 5.666 2.142  
Rest EIHG 7 0 71.937 4.437 1.677  
REST NEIHG 7 0 72.159 5.789 2.188  
 
Source of Variation  DF   SS   MS    F    P   
Between Subjects 6 478.018 79.670    
Between Treatments 4 123.328 30.832 2.033 0.122  
Residual 24 363.971 15.165    
Total 34 965.317     
 
Power of performed test with alpha = 0.050: 0.270 
 
 
 
Resting HR 
One Way Repeated Measures Analysis of Variance Monday, October 21, 2013 
Data source: Data 1 in Resting HR.JNB 
Normality Test (Shapiro-Wilk) Passed (P = 0.278) 
Equal Variance Test: Passed (P = 0.669) 
 
Treatment Name  N  Missing Mean Std Dev SEM  
Rest IV 7 0 70.286 5.342 2.019  
Rest Fam 7 0 68.429 5.862 2.216  
Rest CUFF 7 0 69.286 5.522 2.087  
Rest EIHG 7 0 68.619 6.057 2.289  
REST NEIHG 7 0 68.524 5.689 2.150  
 
Source of Variation  DF   SS   MS    F    P   
Between Subjects 6 584.083 97.347    
Between Treatments 4 17.003 4.251 0.261 0.900  
Residual 24 390.552 16.273    
Total 34 991.638     
 
Power of performed test with alpha = 0.050: 0.050 
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Resting BA Diameter 
Two Way Repeated Measures ANOVA (Two Factor Repetition) Monday, October 21, 2013 
Data source: Data 1 in Resting Diameters.JNB 
Balanced Design 
Dependent Variable: Resting Diameter  
Normality Test (Shapiro-Wilk) Passed (P = 0.932) 
Equal Variance Test: Passed (P = 0.994) 
 
Source of Variation  DF   SS   MS    F    P   
Participant 6 4.749 0.792    
Day 2 0.228 0.114 2.671 0.110  
Day x Participant 12 0.511 0.0426    
Pre-Post 1 0.00146 0.00146 0.213 0.661  
Pre-Post x Participant 6 0.0412 0.00686    
Day x Pre-Post 2 0.00853 0.00426 0.295 0.749  
Residual 12 0.173 0.0144    
Total 41 5.712 0.139    
 
Power of performed test with alpha = 0.0500:  for Day : 0.276 
Power of performed test with alpha = 0.0500:  for Pre-Post : 0.0500 
Power of performed test with alpha = 0.0500:  for Day x Pre-Post : 0.0500 
 
Least square means for Day :  
Group Mean  
CUFF 2.906  
EIHG 2.935  
NEIHG 3.075  
Std Err of LS Mean = 0.0551 
 
Least square means for Pre-Post :  
Group Mean  
Pre 2.978  
Post 2.966  
Std Err of LS Mean = 0.0181 
 
Least square means for Day x Pre-Post :  
Group Mean  
CUFF x Pre 2.894  
CUFF x Post 2.918  
EIHG x Pre 2.942  
EIHG x Post 2.929  
NEIHG x Pre 3.097  
NEIHG x Post 3.052  
Std Err of LS Mean = 0.0454 
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Resting Mean Blood Flow 
Two Way Repeated Measures ANOVA (Two Factor Repetition) Monday, October 21, 2013 
Data source: Data 1 in Resting Flows.JNB 
Balanced Design 
Dependent Variable: Resting Flow  
Normality Test (Shapiro-Wilk) Passed (P = 0.968) 
Equal Variance Test: Passed (P = 0.998) 
 
Source of Variation  DF   SS   MS    F    P   
Participant 6 4926.916 821.153    
Day 2 241.455 120.728 0.357 0.707  
Day x Participant 12 4053.200 337.767    
Pre-Post 1 62.738 62.738 0.382 0.559  
Pre-Post x Participant 6 986.085 164.348    
Day x Pre-Post 2 218.025 109.013 0.980 0.404  
Residual 12 1335.461 111.288    
Total 41 11823.881 288.387    
 
Power of performed test with alpha = 0.0500:  for Day : 0.0500 
Power of performed test with alpha = 0.0500:  for Pre-Post : 0.0500 
Power of performed test with alpha = 0.0500:  for Day x Pre-Post : 0.0500 
 
Least square means for Day :  
Group Mean  
CUFF 31.915  
EIHG 35.306  
NEIHG 29.458  
Std Err of LS Mean = 4.912 
 
Least square means for Pre-Post :  
Group Mean  
Pre 33.448  
Post 31.004  
Std Err of LS Mean = 2.798 
 
Least square means for Day x Pre-Post :  
Group Mean  
CUFF x Pre 32.521  
CUFF x Post 31.309  
EIHG x Pre 34.097  
EIHG x Post 36.515  
NEIHG x Pre 33.727  
NEIHG x Post 25.188  
Std Err of LS Mean = 3.987 
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Peak Mean Blood Flow 
Two Way Repeated Measures ANOVA (Two Factor Repetition) Friday, October 25, 2013 
Data source: Data 1 in Peak Flows.JNB 
Balanced Design 
Dependent Variable: Peak Flow  
Normality Test (Shapiro-Wilk) Passed (P = 0.529) 
Equal Variance Test: Passed (P = 0.810) 
 
Source of Variation  DF   SS   MS    F    P   
Participant 6 473076.739 78846.123    
Day 2 24942.395 12471.198 0.788 0.477  
Day x Participant 12 190008.550 15834.046    
Pre-Post 1 78.128 78.128 0.0103 0.923  
Pre-Post x Participant 6 45699.238 7616.540    
Day x Pre-Post 2 14409.624 7204.812 0.738 0.499  
Residual 12 117198.136 9766.511    
Total 41 865412.811 21107.630    
 
Power of performed test with alpha = 0.0500:  for Day : 0.0500 
Power of performed test with alpha = 0.0500:  for Pre-Post : 0.0500 
Power of performed test with alpha = 0.0500:  for Day x Pre-Post : 0.0500 
 
Least square means for Day :  
Group Mean  
CUFF 399.861  
EIHG 455.248  
NEIHG 446.832  
Std Err of LS Mean = 33.630 
 
Least square means for Pre-Post :  
Group Mean  
Pre 435.345  
Post 432.617  
Std Err of LS Mean = 19.044 
 
Least square means for Day x Pre-Post :  
Group Mean  
CUFF x Pre 419.258  
CUFF x Post 380.465  
EIHG x Pre 464.050  
EIHG x Post 446.446  
NEIHG x Pre 422.726  
NEIHG x Post 470.939  
Std Err of LS Mean = 37.353 
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Resting Shear Rate 
Two Way Repeated Measures ANOVA (Two Factor Repetition) Friday, November 01, 2013 
Data source: Data 1 in Notebook1 
Balanced Design 
Dependent Variable: Resting Shear  
Normality Test (Shapiro-Wilk) Passed (P = 0.468) 
Equal Variance Test: Passed (P = 1.000) 
 
Source of Variation  DF   SS   MS    F    P   
Participant 6 1728.506 288.084    
Day 2 372.167 186.083 1.012 0.392  
Day x Participant 12 2205.789 183.816    
Pre-Post 1 3.146 3.146 0.0768 0.791  
Pre-Post x Participant 6 245.671 40.945    
Day x Pre-Post 2 145.465 72.733 1.233 0.326  
Residual 12 707.707 58.976    
Total 41 5408.451 131.913    
 
 
Power of performed test with alpha = 0.0500:  for Day : 0.0508 
Power of performed test with alpha = 0.0500:  for Pre-Post : 0.0500 
Power of performed test with alpha = 0.0500:  for Day x Pre-Post : 0.0772 
 
Least square means for Day :  
Group Mean  
CUFF 22.508  
EIHG 24.019  
NEIHG 17.086  
Std Err of LS Mean = 3.623 
 
Least square means for Pre-Post :  
Group Mean  
Pre 20.931  
Post 21.478  
Std Err of LS Mean = 1.396 
 
Least square means for Day x Pre-Post :  
Group Mean  
CUFF x Pre 22.638  
CUFF x Post 22.378  
EIHG x Pre 21.291  
EIHG x Post 26.747  
NEIHG x Pre 18.863  
NEIHG x Post 15.309  
Std Err of LS Mean = 2.903 
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Peak Shear Rate 
Two Way Repeated Measures ANOVA (Two Factor Repetition) Friday, November 01, 2013 
Data source: Data 1 in Notebook1 
Balanced Design 
Dependent Variable: Peak Shear  
Normality Test (Shapiro-Wilk) Failed (P < 0.050) 
Equal Variance Test: Passed (P = 0.854) 
 
Source of Variation  DF   SS   MS    F    P   
Participant 6 46928.172 7821.362    
Day 2 935.455 467.728 0.232 0.796  
Day x Participant 12 24187.570 2015.631    
Time 1 1478.599 1478.599 0.839 0.395  
Time x Participant 6 10578.091 1763.015    
Day x Time 2 2921.992 1460.996 0.753 0.492  
Residual 12 23290.520 1940.877    
Total 41 110320.399 2690.741    
 
Power of performed test with alpha = 0.0500:  for Day : 0.0500 
Power of performed test with alpha = 0.0500:  for Time : 0.0500 
Power of performed test with alpha = 0.0500:  for Day x Time : 0.0500 
 
Least square means for Day :  
Group Mean  
CUFF 234.378  
EIHG 227.323  
NEIHG 222.920  
Std Err of LS Mean = 11.999 
 
Least square means for Time :  
Group Mean  
Pre 222.274  
Post 234.140  
Std Err of LS Mean = 9.163 
 
Least square means for Day x Time :  
Group Mean  
CUFF x Pre 239.335  
CUFF x Post 229.422  
EIHG x Pre 219.871  
EIHG x Post 234.775  
NEIHG x Pre 207.616  
NEIHG x Post 238.225  
Std Err of LS Mean = 16.651	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Non-Normalized FMD (% Change) 
Two Way Repeated Measures ANOVA (Two Factor Repetition) Friday, October 25, 2013 
Data source: Data 1 in Non-Normalized FMD.JNB 
Balanced Design 
Dependent Variable: FMD %Change  
Normality Test (Shapiro-Wilk) Passed (P = 1.000) 
Equal Variance Test: Passed (P = 0.569) 
 
Source of Variation  DF   SS   MS    F    P   
Subject 6 721.807 120.301    
Day 2 217.163 108.582 0.809 0.468  
Day x Subject 12 1610.924 134.244    
PrePost 1 11.119 11.119 0.266 0.624  
PrePost x Subject 6 250.814 41.802    
Day x PrePost 2 4.805 2.402 0.0567 0.945  
Residual 12 508.505 42.375    
Total 41 3325.136 81.101    
 
Power of performed test with alpha = 0.0500:  for Day : 0.0500 
Power of performed test with alpha = 0.0500:  for PrePost : 0.0500 
Power of performed test with alpha = 0.0500:  for Day x PrePost : 0.0500 
 
Least square means for Day :  
Group Mean  
CUFF 9.874  
EIHG 13.539  
NEIHG 8.074  
Std Err of LS Mean = 3.097 
 
Least square means for PrePost :  
Group Mean  
Pre 11.010  
Post 9.981  
Std Err of LS Mean = 1.411 
 
Least square means for Day x PrePost :  
Group Mean  
CUFF x Pre 10.862  
CUFF x Post 8.885  
EIHG x Pre 13.763  
EIHG x Post 13.315  
NEIHG x Pre 8.405  
NEIHG x Post 7.743  
Std Err of LS Mean = 2.460 
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Normalized FMD (FMD:AUC) 
Two Way Repeated Measures ANOVA (Two Factor Repetition) Friday, October 25, 2013 
Data source: Data 1 in Normalized FMD.JNB 
Balanced Design 
Dependent Variable: FMDnorm  
Normality Test (Shapiro-Wilk) Passed (P = 0.998) 
Equal Variance Test: Passed (P = 0.447) 
 
Source of Variation  DF   SS   MS    F    P   
Participant 6 199.489 33.248    
Time 1 32.480 32.480 2.082 0.199  
Time x Participant 6 93.600 15.600    
Day 2 16.296 8.148 0.410 0.673  
Day x Participant 12 238.740 19.895    
Time x Day 2 42.323 21.162 1.441 0.275  
Residual 12 176.238 14.686    
Total 41 799.166 19.492    
 
Power of performed test with alpha = 0.0500:  for Time : 0.137 
Power of performed test with alpha = 0.0500:  for Day : 0.0500 
Power of performed test with alpha = 0.0500:  for Time x Day : 0.103 
 
Least square means for Time :  
Group Mean  
Pre 5.156  
Post 3.397  
Std Err of LS Mean = 0.862 
 
Least square means for Day :  
Group Mean  
CUFF 3.410  
EIHG 4.573  
NEIHG 4.847  
Std Err of LS Mean = 1.192 
 
Least square means for Time x Day :  
Group Mean  
Pre x CUFF 3.249  
Pre x EIHG 5.136  
Pre x NEIHG 7.083  
Post x CUFF 3.571  
Post x EIHG 4.010  
Post x NEIHG 2.610  
Std Err of LS Mean = 1.448 
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RVF (% Change) 
Two Way Repeated Measures ANOVA (Two Factor Repetition) Friday, October 25, 2013 
Data source: Data 1 in Plethysmography.JNB 
General Linear Model 
Dependent Variable: % Change  
The following subject was deleted from calculations because of missing data: 2  
Normality Test (Shapiro-Wilk) Passed (P = 0.997) 
Equal Variance Test: Passed (P = 0.997) 
 
Source of Variation  DF   SS   MS    F    P   
Participant 5 886899.241 177379.848 0.741 0.624  
Day 2 1752817.802 876408.901 2.876 0.103  
Day x Participant 10 3046818.347 304681.835    
Pre-Post 1 12967.762 12967.762 0.266 0.628  
Pre-Post x Participant 5 243483.085 48696.617    
Day x Pre-Post 2 776468.553 388234.277 3.407 0.074  
Residual 10 1139471.415 113947.141    
Total 35 7858926.206 224540.749    
 
Power of performed test with alpha = 0.0500:  for Day : 0.294 
Power of performed test with alpha = 0.0500:  for Pre-Post : 0.0500 
Power of performed test with alpha = 0.0500:  for Day x Pre-Post : 0.368 
 
Expected Mean Squares: 
Approximate DF Residual for Day = 10.000  
Approximate DF Residual for Pre-Post = 5.000  
Approximate DF Residual for Participant = 5.185  
 
Expected MS(Day) = var(res) + 2.000 var(Day x Participant) + var(Day) 
Expected MS(Pre-Post) = var(res) + 3.000 var(Pre-Post x Participant) + var(Pre-Post) 
Expected MS(Participant) = var(res) + 2.000 var(Day x Participant) +3.000 var(Pre-Post x Participant) 
+6.000 var(Participant) 
Expected MS(Day x Participant) = var(res) + 2.000 var(Day x Participant) 
Expected MS(Day x Pre-Post) = var(res) + var(Day x Pre-Post) 
Expected MS(Pre-Post x Participant) = var(res) + 3.000 var(Pre-Post x Participant) 
Expected MS(Residual) = var(res) 
 
Least square means for Day :  
Group Mean SEM  
NEIHG 682.173 159.343  
EIHG 390.393 159.343  
CUFF 930.301 159.343  
 
Least square means for Pre-Post :  
Group Mean SEM  
Pre 686.602 52.013  
Post 648.643 52.013  
 
Least square means for Day x Pre-Post :  
Group Mean SEM  
NEIHG x Pre 505.345 137.809  
NEIHG x Post 859.001 137.809  
EIHG x Pre 447.296 137.809  
EIHG x Post 333.490 137.809  
CUFF x Pre 1107.164 137.809  
CUFF x Post 753.438 137.809 
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Correlations between FMD and AUC 
 
Pre CUFF 
Pearson Product Moment Correlation Tuesday, November 05, 2013 
Data source: Data 1 in Pre Cuff Correlation.JNB 
Cell Contents: 
Correlation Coefficient 
P Value 
Number of Samples 
 
  FMD  
Shear 0.625  
 0.133  
 7  
Post CUFF 
Pearson Product Moment Correlation Tuesday, November 05, 2013 
Data source: Data 1 in Notebook1 
 
Cell Contents: 
Correlation Coefficient 
P Value 
Number of Samples 
 
  FMD  
Shear 0.132  
 0.779  
 7  
 
Pre EIHG 
Pearson Product Moment Correlation Tuesday, November 05, 2013 
Data source: Data 1 in Notebook1 
Cell Contents: 
Correlation Coefficient 
P Value 
Number of Samples 
 
  FMD  
Shear -0.191  
 0.681  
 7 
 
Post EIHG 
Pearson Product Moment Correlation Tuesday, November 05, 2013 
Data source: Data 1 in Notebook1 
Cell Contents: 
Correlation Coefficient 
P Value 
Number of Samples 
 
  FMD  
Shear -0.306  
 0.505  
 7 
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Pre NEIHG 
Pearson Product Moment Correlation Tuesday, November 05, 2013 
Data source: Data 1 in Notebook1 
Cell Contents: 
Correlation Coefficient 
P Value 
Number of Samples 
 
  FMD  
SHEAR -0.271  
 0.557  
 7 
 
Post NEIHG 
Pearson Product Moment Correlation Tuesday, November 05, 2013 
Data source: Data 1 in Notebook1 
Cell Contents: 
Correlation Coefficient 
P Value 
Number of Samples 
 
  FMD  
SHEAR 0.237  
 0.608  
 7 
 
Correlations of FMD between EIHG and CUFF Testing Days 
Pearson Product Moment Correlation Wednesday, November 20, 2013 
Data source: Data 1 in Non-Normalized FMD.JNB 
 
Cell Contents: 
Correlation Coefficient 
P Value 
Number of Samples 
 
  EIHG Pre  
CUFF Pre -0.287  
 0.533  
 7 
Pearson Product Moment Correlation Wednesday, November 20, 2013 
 
Cell Contents: 
Correlation Coefficient 
P Value 
Number of Samples 
 
  EIHG Pre  
CUFF Pre -0.346  
 0.502  
 6  
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Appendix Q: Reproducibility 
Inter-Observer Reproducibility 
ID Testing Day Investigator 1 Investigator 2 X SD Cv 
2 Pre CUFF 2.32 2.21 2.27 0.08 3.53 
3 Pre CUFF 2.68 2.73 2.71 0.04 1.36 
4 Pre CUFF 2.84 2.73 2.78 0.08 2.73 
5 Pre CUFF 3.42 3.32 3.37 0.07 2.20 
6 Pre CUFF 2.97 3.09 3.03 0.09 2.94 
7 Pre CUFF 2.91 2.93 2.92 0.02 0.60 
8 Pre CUFF 3.12 3.11 3.11 0.01 0.22 
2 Post CUFF 2.36 2.20 2.28 0.11 4.97 
3 Post CUFF 2.71 2.76 2.73 0.04 1.30 
4 Post CUFF 2.77 2.77 2.77 0.00 0.10 
5 Post CUFF 3.45 3.47 3.46 0.01 0.37 
6 Post CUFF 2.90 2.87 2.88 0.02 0.81 
7 Post CUFF 2.79 2.65 2.72 0.10 3.55 
8 Post CUFF 3.44 3.27 3.35 0.12 3.53 
   
CC 0.97 Cv 2.01 
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Method Error 
ID Testing Day Investigator 1 Investigator 2 Difference 
	   	  2 Pre CUFF 2.32 2.21 0.11 
	   	  3 Pre CUFF 2.68 2.73 -0.05 
	   	  4 Pre CUFF 2.84 2.73 0.11 
	   	  5 Pre CUFF 3.42 3.32 0.10 
	   	  6 Pre CUFF 2.97 3.09 -0.13 
	   	  7 Pre CUFF 2.91 2.93 -0.02 
	   	  8 Pre CUFF 3.12 3.11 0.01 
	   	  2 Post CUFF 2.36 2.20 0.16 
	   	  3 Post CUFF 2.71 2.76 -0.05 
	   	  4 Post CUFF 2.77 2.77 0.00 
	   	  5 Post CUFF 3.45 3.47 -0.02 
	   	  6 Post CUFF 2.90 2.87 0.03 
	   	  7 Post CUFF 2.79 2.65 0.14 
	   	  8 Post CUFF 3.44 3.27 0.17 
	   	  2 
 
2.21 
  	   	  3 
 
2.73 
  	   	  4 
 
2.73 
  	   	  5 
 
3.32 
  	   	  6 
 
3.09 
  	   	  7 
 
2.93 
  	   	  8 
 
3.11 
  	   	  2 
 
2.20 
  	   	  3 
 
2.76 
  	   	  4 
 
2.77 
  	   	  5 
 
3.47 
  	   	  6 
 
2.87 
  	   	  7 
 
2.65 
  	   	  8 
 
3.27 
  	   	  
 
Grand Mean 2.89 Mean Difference 0.04 
	   	  
   
SD Difference 0.09 
	   	  
   
Method Error 3.16 
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Intra-Observer Reproducibility 
ID CUFF EIHG X SD Cv 
2 2.3242 2.1224 2.22 0.14 6.41812389 
3 2.6812 2.6128 2.65 0.05 1.827204527 
4 2.8376 2.8872 2.86 0.04 1.225282852 
5 3.4228 3.4878 3.46 0.05 1.330186692 
6 2.9678 3.1057 3.04 0.10 3.210999428 
7 2.9076 2.9293 2.92 0.02 0.525765977 
8 3.1154 3.4487 3.28 0.24 7.180837896 
  
CC 0.97 Cv 3.102628752 
 	   	   	   	   	  
 	   	   	   	   	  ID CUFF EIHG Difference 
	   	  2 2.3242 2.1224 0.2018 
	   	  3 2.6812 2.6128 0.0684 
	   	  4 2.8376 2.8872 -0.0496 
	   	  5 3.4228 3.4878 -0.065 
	   	  6 2.9678 3.1057 -0.1379 
	   	  7 2.9076 2.9293 -0.0217 
	   	  8 3.1154 3.4487 -0.3333 
	   	  2 2.1224 
	   	   	   	  3 2.6128 
	   	   	   	  4 2.8872 
	   	   	   	  5 3.4878 
	   	   	   	  6 3.1057 
	   	   	   	  7 2.9293 
	   	   	   	  8 3.4487 
	   	   	   	  
	  
Grand Mean 2.92 Mean Difference -0.05 
	  
	     
SD Difference 0.17 
	  
	     
Method Error 5.71 
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Appendix R: Vascular Function Scatter Plots 
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